Press Releases

WASHINGTON – U.S. Senators Mark Warner (D–Va.) and Tim Scott (R–S.C.) introduced the Long-Term Care (LTC) Pharmacy Definition Act of 2020. This bipartisan legislation, if passed, will ensure seniors requiring long-term care have access to the medication and treatments they need. This bill would also codify an adaptable definition for “long-term care pharmacy” to enhance clarity and consistency across diverse programs and agencies. Without adding new costs to the healthcare system, a clear federal definition for LTC pharmacy would provide policymakers and regulators with the tools needed to facilitate the unique supports that these pharmacies offer, within both current models and the innovative models of the future.  

 "Long-term care pharmacies are essential to providing quality care to millions of our nation’s seniors. Unfortunately, under existing rules, they are regulated in the same way as more traditional retail pharmacies, which has created unnecessary bureaucracy around providing life-saving medication and services for a vulnerable population," said Sen. Warner. “That’s why we’re introducing legislation that will create a distinct definition for long-term care pharmacies to better reflect the specialized care they provide for the senior population they serve."

"This commonsense legislation would ensure clarity and consistency for our long-term care pharmacies without adding costs to our healthcare system," said Sen. Scott. “I urge my colleagues to support this bipartisan bill, which will make it easier for this important sector to navigate regulatory confusion and allow them to care and provide for our nation’s seniors."

Congressmen Markwayne Mullin (R-OK) and Kurt Schrader (R-OR) introduced companion legislation in the House of Representatives.

"Long Term Care Pharmacies provide critical services for seniors, who often require multiple prescriptions to maintain their health. Because there is no statuary definition for LTC Pharmacies, they must negotiate a patchwork of vague, inconsistent provisions, which could disrupt services and impact care for seniors. This commonsense legislation will help agencies give more consistent regulatory direction as well as streamline services to residents,” said Rep. Mullin.

"The personal services that long term care pharmacies provide seniors, many who take upwards of 10 medications per day, are critical for the health and wellness of millions of Americans,” said Rep. Schrader. "COVID-19 has had a disproportionate effect on this vulnerable population and now more than ever a consistent regulatory framework that defines long term care pharmacies is crucial. This bipartisan legislation will offer greater governmental oversight and create regulatory consistency across multiple federal agencies."

"Now more than ever, as the nation’s LTC community copes with the unprecedented impact of COVID-19, establishing a clear and consistent regulatory framework for LTC pharmacies is essential,” said Alan G. Rosenbloom, President and CEO of the Senior Care Pharmacy Coalition. “We commend Senators Scott and Warner as well as Congressmen Schrader and Mullin for recognizing the unique value proposition LTC pharmacies offer seniors in nursing homes and other LTC facilities by introducing this much-needed legislation. The patient care services LTC pharmacies provide, including the 12 prescriptions per day per person on average, are crucial to the health and safety of our most vulnerable citizens."

Full text of the bill is available here.

###

WASHINGTON - Today, U.S. Sen. Mark R. Warner (D-VA) joined Sen. Patty Murray (D-WA), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee, and 44 of their Democratic Senate colleagues in writing to Vice President Mike Pence, and Coronavirus Task Force Coordinator Dr. Deborah Birx, urging the Trump Administration to reverse recent changes requiring hospitals to report data to a new system set up by the Department of Health and Human Services instead of the National Healthcare Safety Network (NHSN) which is run by the Centers for Disease Control and Prevention (CDC) and has been in use for over a decade.  

“We write today to urge you to withdraw your confusing and harmful changes to hospital reporting requirements for Coronavirus Disease 2019 (COVID-19). In the midst of a global pandemic, these changes pose serious challenges to the nation’s response by increasing the data management burden for hospitals, potentially delaying critical supply shipments, compromising access to key data for many states, and reducing transparency for the public. The Trump Administration’s mismanagement of the COVID-19 response and refusal to heed public health expertise continue to put the country in a dangerous position,” write the Senators.

Earlier this year, Senator Murray wrote to the Trump Administration questioning its decision to award a $10 million non-competitive contract to develop a duplicative data system—the system which the Administration is now requiring hospitals switch to in place of NHSN, justifying the change as necessary to reduce duplicative hospital reporting that this Administration itself created. The Administration has yet to respond to her letter or explain how the new system differs from NHSN or improves reporting.

The letter the Senators sent today details how the sudden switch to the new system could undermine the COVID-19 response on several fronts: hospitals unable to switch within 48 hours could lose access to critical supplies; states who have built their own response and data systems on the NHSN could lose access to critical information; and the decision to circumvent CDC could lead to disruption in the data collected, questions about its accuracy, and hampered access for public health experts and the general public.

Before posing several questions to Administration about the shift, the Senators’ letter concludes, “Without adequate data, the country has been unable to appropriately adjust our response to COVID-19—a reality highlighted by the dearth of reliable data on the heavy burden of COVID-19 on communities of color and other vulnerable populations. The American people deserve to know the true scope of the pandemic, and that can only happen if public health experts lead in collecting and reporting data accurately and transparently. By abruptly changing the reporting process by requiring hospitals to report to HHS and circumventing CDC, we are concerned there will be a disruption in the data collected and questions about the accuracy of that data.”

The letter was also signed by Senators Gary Peters (D-MI), Chuck Schumer (D-NY), Amy Klobuchar (D-MN), Richard Blumenthal (D-CT), Robert Menendez (D-NJ), Michael Bennet (D-CO), Sherrod Brown (D-OH), Tom Carper (D-DE), Bob Casey (D-PA), Dick Durbin (D-IL), Tammy Baldwin (D-WI), Ed Markey (D-MA), Tom Udall (D-NM), Jack Reed (D-RI), Ron Wyden (D-OR), Debbie Stabenow (D-MI), Tim Kaine (D-VA), Martin Heinrich (D-NM), Patrick Leahy (D-VT), Ben Cardin (D-MD), Jeanne Shaheen (D-NH), Elizabeth Warren (D-MA), Tina Smith (D-MN), Sheldon Whitehouse (D-RI), Angus King (I-ME), Bernie Sanders (I-VT), Cory Booker (D-NJ), Maria Cantwell (D-WA), Catherine Cortez Masto (D-NV), Kirsten Gillibrand (D-NY), Maggie Hassan (D-NH), Doug Jones (D-AL), Kamala Harris (D-CA), Chris Van Hollen (D-MD), Mazie Hirono (D-HI), Brian Schatz (D-HI), Chris Coons (D-DE), Jeff Merkley (D-OR), Chris Murphy (D-CT), Tammy Duckworth (D-IL), Jacky Rosen (D-NV), Jon Tester (D-MT), Dianne Feinstein (D-CA), and Joe Manchin (D-WV).

See the full text of the letter below. A PDF is available HERE.

July 17, 2020

The Honorable Michael R. Pence

Vice President of the United States

The White House

1600 Pennsylvania Avenue, NW

Washington, DC 20500

The Honorable Deborah Birx, M.D.

Coronavirus Task Force Coordinator

The White House

1600 Pennsylvania Avenue, NW

Washington, DC 20500 

Dear Vice President Pence and Ambassador Birx,

We write today to urge you to withdraw your confusing and harmful changes to hospital reporting requirements for Coronavirus Disease 2019 (COVID-19). In the midst of a global pandemic, these changes pose serious challenges to the nation’s response by increasing the data management burden for hospitals, potentially delaying critical supply shipments, compromising access to key data for many states, and reducing transparency for the public. The Trump Administration’s mismanagement of the COVID-19 response and refusal to heed public health expertise continue to put the country in a dangerous position.

The Centers for Disease Control and Prevention (CDC) is the primary repository of the nation’s public health data, including data on COVID-19. Leading public health groups agree that CDC is “uniquely qualified to collect, analyze and disseminate information regarding infectious diseases.”[1] The agency’s National Healthcare Safety Network (NHSN), which has played a critical role in collecting public health data for fifteen years, is used in over 25,000 health care facilities across the United States for mandatory reporting of infection-related data and for voluntary use for quality improvement. NHSN’s COVID-19 reporting module for hospitals, which launched on March 27, 2020, enables facilities to submit data on cases, personnel, and supply shortages. Following the launch of the COVID-19 module, Vice President Pence and the Centers for Medicare and Medicaid Services (CMS) required both hospitals and nursing homes to report to NHSN. Within six weeks of its launch, over 60 percent of the nation’s hospitals were reporting daily through the NHSN COVID-19 module. As a result, many states have built their own COVID-19 data management systems on this NHSN data feed. 

Despite the CDC’s well-established reporting mechanism, in early April, the Assistant Secretary for Preparedness and Response (ASPR) issued a six-month contract for $10 million on a non-competitive basis to TeleTracking to create an alternate hospital reporting pathway to the Department of Health and Human Services (HHS).  The new system inexplicably created a second, duplicative mechanism through which hospitals could report the same information already collected through NHSN – this time managed by a private contractor.

On July 13, 2020, you directed hospitals to cease reporting data to NHSN and instead report to HHS via the newly established TeleTracking or HHS Protect systems within 48 hours, splitting out hospital reporting and nursing home reporting into separate systems. Your request states “[a]s of July 15, 2020, hospitals should no longer report the COVID-19 information in this document to the National Healthcare Safety Network site. Please select one of the above methods to use instead.” [2] You further unreasonably urged states to consider deploying the National Guard to the nation’s hospitals to support this data reporting change.[3] 

The change in reporting mechanism that you have ordered will only exacerbate ongoing challenges to tracking COVID-19 data, which is already hampered by serious limitations in how data is collected, managed, reported, and disseminated.  Combined with insufficient testing capacity, this has led to an incomplete picture of the scope and impact of the COVID-19 pandemic in the United States. The CDC has indicated it believes the true number of cases in the country is 10 times higher than the official counts.[4]

The CARES Act, signed into law by President Trump on March 27, 2020, included $500 million for the CDC Data Modernization Initiative, to help CDC update, streamline, and scale up data collection. Rather than focusing on these critical efforts, however, the Trump Administration has chosen to instead reorganize and redirect data flow. This decision by the Administration to change the reporting process in the midst of a pandemic is deeply troubling. While there are certainly steps needed to improve public health data collection, waging interdepartmental jurisdictional battles to sideline our nation’s leading public health agency in the middle of an historic pandemic is bad management at best and malpractice at worst.  

Rather than focusing on emergency response and patient care, hospitals must now spend precious time and resources changing their processes for reporting data.  You also announced that as soon as next week shipments of critical supplies that are in shortage, including personal protective equipment (PPE), will be based on data collected from these new systems. That means hospitals that are unable to change their reporting in under 48 hours may lose out on access to those critical supplies. Furthermore, the lack of transparency under the new data reporting requirements raises major concerns regarding their distribution. An opaque data collection mechanism invites political interference in processes and decisions that must be driven by data and public health. 

Moreover, the abrupt change in data collection mechanisms threatens to leave states that rely on the NHSN data feeds in the dark about the spread of COVID-19 in their communities. By eliminating NHSN as the data source, and moving all federal hospital reporting to two systems that do not automatically share data or analytic reports created by CDC medical epidemiologists with states, the federal government is significantly undermining states’ ability to effectively respond to this crisis. This is unacceptable at any point in a pandemic – it is especially dangerous in a moment where cases are surging to unprecedented levels, with more than 66,000 new cases reported in the U.S. on July 15.[5]This Administration has repeatedly underscored the role and responsibility of states in responding to COVID-19, yet steps like these actively undermine states’ responses.

Without adequate data, the country has been unable to appropriately adjust our response to COVID-19—a reality highlighted by the dearth of reliable data on the heavy burden of COVID-19 on communities of color and other vulnerable populations. The American people deserve to know the true scope of the pandemic, and that can only happen if public health experts lead in collecting and reporting data accurately and transparently. By abruptly changing the reporting process by requiring hospitals to report to HHS and circumventing CDC, we are concerned there will be a disruption in the data collected and questions about the accuracy of that data.

The federal government must ensure data collection is led by public health experts, remains transparent and accurate, and is appropriately safeguarded. We urge that these changes to COVID-19 hospital reporting requirements be halted immediately. 

Additionally, we request answers to the questions below about the decision to change data reporting requirements for hospitals. Please respond to the questions by July 31, 2020:

1.       What is the justification for requiring hospitals to change their reporting within 48 hours?

2.      What is the public health rationale for moving data collection from the CDC to HHS?

3.      Will HHS or TeleTracking now provide analytic reports of the hospital data to other federal government agencies, state health departments, and hospital facilities as CDC previously did?

4.      Will HHS or TeleTracking publicly report a portion of the hospital data as CDC previously did?

5.      To the extent HHS is limiting access to data or analytic reports for federal agencies, state health departments, hospital facilities, and/or the public, what is the justification for such limitations? 

6.      How will data reported to HHS be transmitted to CDC to support ongoing holistic public health surveillance and analysis efforts of COVID-19 infections?

7.      Please detail any differences between the NHSN, TeleTracking, and HHS Protect systems on the basis of technological capability or data collected.

a.      Please explain why NHSN is insufficient to effectively collect and report relevant COVID-19 data.

b.      Is NHSN unable to determine any resource allotments or response activities for which TeleTracking or HHS Protect offers new capabilities?

                                                              i.      If so, what would be required to update NHSN in order to allow it to perform this function? Why was this not pursued?

                                                           ii.      If not, please explain the stated justification for these changes.

8.     Which office or entity will be in charge of managing the data at HHS?

9.      Please describe the steps the Administration is taking to ensure data is both accurate and readily available for CDC, states, public health departments, Congress, the research community, and the public.

10.  How will the Administration ensure a transparent data collection process?

11.   How will the Administration ensure improved collection of demographic data, including data broken down by race ethnicity, age, geography, disability status, sex (including sexual orientation and gender identity), and socioeconomic status?

12.  What funding is being used to support the new HHS data collection system?  Please include details about which COVID-19 emergency supplemental bill appropriated this funding and the justification for HHS to use it for this purpose.  Please also include estimated costs for developing and implementing this new system as well as any other related expenses, the plans for its long-term use, and projections for its annual costs. 

We look forward to your responses.

Sincerely,

###

Today, U.S. Sen. Mark R. Warner joined Sen. Patty Murray (D-WA) and 44 of her Democratic Senate colleagues in writing to Vice President Mike Pence, and Coronavirus Task Force Coordinator Dr. Deborah Birx, urging the Trump Administration to reverse recent changes requiring hospitals to report data to a new system set up by the Department of Health and Human Services instead of the National Healthcare Safety Network (NHSN) which is run by the Centers for Disease Control and Prevention (CDC) and has been in use for over a decade.

 “We write today to urge you to withdraw your confusing and harmful changes to hospital reporting requirements for Coronavirus Disease 2019 (COVID-19). In the midst of a global pandemic, these changes pose serious challenges to the nation’s response by increasing the data management burden for hospitals, potentially delaying critical supply shipments, compromising access to key data for many states, and reducing transparency for the public. The Trump Administration’s mismanagement of the COVID-19 response and refusal to heed public health expertise continue to put the country in a dangerous position,” write the Senators.

The letter the Senators sent today details how the sudden switch to the new system could undermine the COVID-19 response on several fronts: hospitals unable to switch within 48 hours could lose access to critical supplies; states who have built their own response and data systems on the NHSN could lose access to critical information; and the decision to circumvent CDC could lead to disruption in the data collected, questions about its accuracy, and hampered access for public health experts and the general public.

Before posing several questions to Administration about the shift, the Senators’ letter concludes, “Without adequate data, the country has been unable to appropriately adjust our response to COVID-19—a reality highlighted by the dearth of reliable data on the heavy burden of COVID-19 on communities of color and other vulnerable populations. The American people deserve to know the true scope of the pandemic, and that can only happen if public health experts lead in collecting and reporting data accurately and transparently. By abruptly changing the reporting process by requiring hospitals to report to HHS and circumventing CDC, we are concerned there will be a disruption in the data collected and questions about the accuracy of that data.”

The letter was also signed by Sens. Gary Peters (D-MI), Chuck Schumer (D-NY), Amy Klobuchar (D-MN), Richard Blumenthal (D-CT), Robert Menendez (D-NJ), Michael Bennet (D-CO), Sherrod Brown (D-OH), Tom Carper (D-DE), Bob Casey (D-PA), Dick Durbin (D-IL), Tammy Baldwin (D-WI), Ed Markey (D-MA), Tom Udall (D-NM), Jack Reed (D-RI), Ron Wyden (D-OR), Debbie Stabenow (D-MI), Tim Kaine (D-VA), Martin Heinrich (D-NM), Patrick Leahy (D-VT), Ben Cardin (D-MD), Jeanne Shaheen (D-NH), Elizabeth Warren (D-MA), Tina Smith (D-MN), Sheldon Whitehouse (D-RI), Angus King (I-ME), Bernie Sanders (I-VT), Cory Booker (D-NJ), Maria Cantwell (D-WA), Catherine Cortez Masto (D-NV), Kirsten Gillibrand (D-NY), Maggie Hassan (D-NH), Doug Jones (D-AL), Kamala Harris (D-CA), Chris Van Hollen (D-MD), Mazie Hirono (D-HI), Brian Schatz (D-HI), Chris Coons (D-DE), Jeff Merkley (D-OR), Chris Murphy (D-CT), Tammy Duckworth (D-IL), Jacky Rosen (D-NV), Jon Tester (D-MT), Dianne Feinstein (D-CA), and Joe Manchin (D-WV).

 

See the full text of the letter below. A PDF is available HERE.

July 17, 2020

The Honorable Michael R. Pence

Vice President of the United States

The White House

1600 Pennsylvania Avenue, NW

Washington, DC 20500

The Honorable Deborah Birx, M.D.

Coronavirus Task Force Coordinator

The White House

1600 Pennsylvania Avenue, NW

Washington, DC 20500

Dear Vice President Pence and Ambassador Birx,

We write today to urge you to withdraw your confusing and harmful changes to hospital reporting requirements for Coronavirus Disease 2019 (COVID-19). In the midst of a global pandemic, these changes pose serious challenges to the nation’s response by increasing the data management burden for hospitals, potentially delaying critical supply shipments, compromising access to key data for many states, and reducing transparency for the public. The Trump Administration’s mismanagement of the COVID-19 response and refusal to heed public health expertise continue to put the country in a dangerous position.

The Centers for Disease Control and Prevention (CDC) is the primary repository of the nation’s public health data, including data on COVID-19. Leading public health groups agree that CDC is “uniquely qualified to collect, analyze and disseminate information regarding infectious diseases.”[1] The agency’s National Healthcare Safety Network (NHSN), which has played a critical role in collecting public health data for fifteen years, is used in over 25,000 health care facilities across the United States for mandatory reporting of infection-related data and for voluntary use for quality improvement. NHSN’s COVID-19 reporting module for hospitals, which launched on March 27, 2020, enables facilities to submit data on cases, personnel, and supply shortages. Following the launch of the COVID-19 module, Vice President Pence and the Centers for Medicare and Medicaid Services (CMS) required both hospitals and nursing homes to report to NHSN. Within six weeks of its launch, over 60 percent of the nation’s hospitals were reporting daily through the NHSN COVID-19 module. As a result, many states have built their own COVID-19 data management systems on this NHSN data feed. 

Despite the CDC’s well-established reporting mechanism, in early April, the Assistant Secretary for Preparedness and Response (ASPR) issued a six-month contract for $10 million on a non-competitive basis to TeleTracking to create an alternate hospital reporting pathway to the Department of Health and Human Services (HHS).  The new system inexplicably created a second, duplicative mechanism through which hospitals could report the same information already collected through NHSN – this time managed by a private contractor.

On July 13, 2020, you directed hospitals to cease reporting data to NHSN and instead report to HHS via the newly established TeleTracking or HHS Protect systems within 48 hours, splitting out hospital reporting and nursing home reporting into separate systems. Your request states “[a]s of July 15, 2020, hospitals should no longer report the COVID-19 information in this document to the National Healthcare Safety Network site. Please select one of the above methods to use instead.” [2] You further unreasonably urged states to consider deploying the National Guard to the nation’s hospitals to support this data reporting change.[3]

The change in reporting mechanism that you have ordered will only exacerbate ongoing challenges to tracking COVID-19 data, which is already hampered by serious limitations in how data is collected, managed, reported, and disseminated.  Combined with insufficient testing capacity, this has led to an incomplete picture of the scope and impact of the COVID-19 pandemic in the United States. The CDC has indicated it believes the true number of cases in the country is 10 times higher than the official counts.[4]

The CARES Act, signed into law by President Trump on March 27, 2020, included $500 million for the CDC Data Modernization Initiative, to help CDC update, streamline, and scale up data collection. Rather than focusing on these critical efforts, however, the Trump Administration has chosen to instead reorganize and redirect data flow. This decision by the Administration to change the reporting process in the midst of a pandemic is deeply troubling. While there are certainly steps needed to improve public health data collection, waging interdepartmental jurisdictional battles to sideline our nation’s leading public health agency in the middle of an historic pandemic is bad management at best and malpractice at worst.

Rather than focusing on emergency response and patient care, hospitals must now spend precious time and resources changing their processes for reporting data.  You also announced that as soon as next week shipments of critical supplies that are in shortage, including personal protective equipment (PPE), will be based on data collected from these new systems. That means hospitals that are unable to change their reporting in under 48 hours may lose out on access to those critical supplies. Furthermore, the lack of transparency under the new data reporting requirements raises major concerns regarding their distribution. An opaque data collection mechanism invites political interference in processes and decisions that must be driven by data and public health.

Moreover, the abrupt change in data collection mechanisms threatens to leave states that rely on the NHSN data feeds in the dark about the spread of COVID-19 in their communities. By eliminating NHSN as the data source, and moving all federal hospital reporting to two systems that do not automatically share data or analytic reports created by CDC medical epidemiologists with states, the federal government is significantly undermining states’ ability to effectively respond to this crisis. This is unacceptable at any point in a pandemic – it is especially dangerous in a moment where cases are surging to unprecedented levels, with more than 66,000 new cases reported in the U.S. on July 15.[5] This Administration has repeatedly underscored the role and responsibility of states in responding to COVID-19, yet steps like these actively undermine states’ responses.

Without adequate data, the country has been unable to appropriately adjust our response to COVID-19—a reality highlighted by the dearth of reliable data on the heavy burden of COVID-19 on communities of color and other vulnerable populations. The American people deserve to know the true scope of the pandemic, and that can only happen if public health experts lead in collecting and reporting data accurately and transparently. By abruptly changing the reporting process by requiring hospitals to report to HHS and circumventing CDC, we are concerned there will be a disruption in the data collected and questions about the accuracy of that data.

The federal government must ensure data collection is led by public health experts, remains transparent and accurate, and is appropriately safeguarded. We urge that these changes to COVID-19 hospital reporting requirements be halted immediately.

Additionally, we request answers to the questions below about the decision to change data reporting requirements for hospitals. Please respond to the questions by July 31, 2020:

  1. What is the justification for requiring hospitals to change their reporting within 48 hours?
  2. What is the public health rationale for moving data collection from the CDC to HHS?
  3. Will HHS or TeleTracking now provide analytic reports of the hospital data to other federal government agencies, state health departments, and hospital facilities as CDC previously did?
  4. Will HHS or TeleTracking publicly report a portion of the hospital data as CDC previously did?
  5. To the extent HHS is limiting access to data or analytic reports for federal agencies, state health departments, hospital facilities, and/or the public, what is the justification for such limitations?
  6. How will data reported to HHS be transmitted to CDC to support ongoing holistic public health surveillance and analysis efforts of COVID-19 infections?
  7. Please detail any differences between the NHSN, TeleTracking, and HHS Protect systems on the basis of technological capability or data collected.
    1. Please explain why NHSN is insufficient to effectively collect and report relevant COVID-19 data.
    2. Is NHSN unable to determine any resource allotments or response activities for which TeleTracking or HHS Protect offers new capabilities?

                                                              i.      If so, what would be required to update NHSN in order to allow it to perform this function? Why was this not pursued?

                                                            ii.      If not, please explain the stated justification for these changes.

  1. Which office or entity will be in charge of managing the data at HHS?
  2. Please describe the steps the Administration is taking to ensure data is both accurate and readily available for CDC, states, public health departments, Congress, the research community, and the public.
  3. How will the Administration ensure a transparent data collection process?
  4. How will the Administration ensure improved collection of demographic data, including data broken down by race ethnicity, age, geography, disability status, sex (including sexual orientation and gender identity), and socioeconomic status?
  5. What funding is being used to support the new HHS data collection system?  Please include details about which COVID-19 emergency supplemental bill appropriated this funding and the justification for HHS to use it for this purpose.  Please also include estimated costs for developing and implementing this new system as well as any other related expenses, the plans for its long-term use, and projections for its annual costs. 

We look forward to your responses.

Sincerely,

 ###

 

WASHINGTON – U.S. Sen. Mark R. Warner (D-Va) joined Sen. Tammy Baldwin (D-WI) in an amendment to the National Defense Authorization Act of 2021 (NDAA) that would require President Trump to unlock the full authority and power of the Defense Production Act to scale up nation-wide production of the testing supplies, personal protective equipment, and medical equipment needed at the local level to address the ongoing COVID-19 pandemic.

“New coronavirus cases are rising in states across the country, which means we need more testing supplies, more testing, and more personal protective equipment for workers on the frontlines of this pandemic,” said Senator Baldwin. “President Trump’s response to this pandemic has been a failure of leadership, so this amendment will force action to increase national production of testing supplies, personal protective equipment, and medical equipment needed to save lives.”

The amendment includes legislation she introduced in April with Senator Chris Murphy (D-CT). The Medical Supply Transparency and Delivery Act requires the president to utilize all available authorities under the Defense Production Act to mobilize a federal response to the pandemic through an equitable and transparent process. Key parts of Baldwin’s legislation are included in the House-passed HEROES Act, but the Republican majority in the Senate has failed to take action on the legislation.

In addition to Sen. Warner, the amendment is cosponsored by Senate Democratic Leader Chuck Schumer (D-NY) and Senators Chris Murphy (D-CT), Michael Bennet (D-CO), Richard Blumenthal (D-CT), Cory Booker (D-NJ), Sherrod Brown (D-OH), Tammy Duckworth (D-IL), Dick Durbin (D-IL), Kamala D. Harris (D-CA), Maggie Hassan (D-NH), Mazie Hirono (D-HI), Doug Jones (D-AL), Tim Kaine (D-VA), Amy Klobuchar (D-MN), Joe Manchin (D-WV), Ed Markey (D-MA), Jeff Merkley (D-OR), Bob Menendez (D-NJ), Brian Schatz (D-HI), Jeanne Shaheen (D-NH), Debbie Stabenow (D-MI), Jacky Rosen (D-NV), and Elizabeth Warren (D-MA). 

The NDAA is being considered on the Senate floor this week.

The full amendment is available here.

 

###

WASHINGTON, D.C. – U.S. Senators Mark R. Warner and Tim Kaine cosponsored an amendment to the National Defense Authorization Act of 2021 (NDAA) that would require President Trump to unlock the full authority and power of the Defense Production Act to scale up nationwide production of the testing supplies, personal protective equipment, and medical equipment needed at the local level to address the ongoing COVID-19 pandemic.

“As coronavirus cases continue to rise throughout Virginia and the country, it’s vital that we continue pushing for more testing and personal protective equipment,”  the Senators said. “Several months into this crisis, the Administration has failed to protect Americans. This amendment will help ensurewe have the resources needed to save American lives."   

The amendment includes the Medical Supply Transparency and Delivery Act, legislation the Senators cosponsored to require the president to utilize all available authorities under the Defense Production Act to mobilize a federal response to the pandemic through an equitable and transparent process. Key parts of the legislation are included in the House-passed HEROES Act, but the Republican majority in the Senate has failed to take action on the legislation.

The amendment, led by U.S. Senator Tammy Baldwin, is also cosponsored by Senate Democratic Leader Chuck Schumer (D-NY) and Senators Chris Murphy (D-CT), Michael Bennet (D-CO), Richard Blumenthal (D-CT), Cory Booker (D-NJ), Sherrod Brown (D-OH), Tammy Duckworth (D-IL), Dick Durbin (D-IL), Kamala D. Harris (D-CA), Maggie Hassan (D-NH), Mazie Hirono (D-HI), Doug Jones (D-AL), Amy Klobuchar (D-MN), Joe Manchin (D-WV), Ed Markey (D-MA), Jeff Merkley (D-OR), Bob Menendez (D-NJ), Brian Schatz (D-HI), Jeanne Shaheen (D-NH), Debbie Stabenow (D-MI), Jacky Rosen (D-NV), and Elizabeth Warren (D-MA).

The NDAA is being considered on the Senate floor this week. 

The full amendment is available here.

###

WASHINGTON – Today, U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) joined Sen. Jon Tester (D-MT) and 44 Senate colleagues in introducing a resolution officially condemning the Trump Administration’s “reckless” effort to dismantle the Affordable Care Act (ACA), which provides coverage for millions of Americans. The Senate resolution also demands that the Department of Justice (DOJ) defend existing law in court and halt its efforts to repeal the health care protections for millions – including 133 million Americans with pre-existing conditions— in the middle of a public health emergency.

“The Trump Administration has made it clear that it will not stop its assault on our nation’s health care law until millions of Americans have lost the protections and coverage they desperately need,” said Sen. Warner. “This resolution affirms what we have said for years – that this Administration’s efforts to dismantle the Affordable Care Act are despicable and put too many vulnerable Virginians at risk. The Department of Justice must immediately put a stop to these efforts and fight to increase access to health care during the largest public health crisis in a generation.” 

“To rip health care away from millions of people during a pandemic would be like dousing a fire with gasoline,” said Kaine. “For the sake of the more than 431,000 Virginians benefiting from Medicaid expansion, more than 3 million Virginians with pre-existing conditions, and all else who rely on the ACA for affordable coverage and consumer protections, I oppose this administration’s latest display of inept cruelty.” 

Last week, the DOJ and a group of Republican Attorneys General submitted a brief to the U.S. Supreme Court urging it to invalidate the ACA and pull the rug out from underneath the millions of Americans with preexisting conditions who depend on the law for health care coverage. This move would take away health care coverage for more than 23 million Americans who receive health care coverage through the ACA marketplaces.

Additionally, if the Supreme Court agrees to overturn the ACA, it could sabotage protections for more than 3 million Virginians living with a preexisting condition such as COVID-19, diabetes, asthma, or cancer, potentially exposing them to annual or lifetime caps, medical underwriting for their insurance coverage, or denials for the care they need. Across the board, the Commonwealth could lose needed federal funds, causing significant job losses and jeopardizing the viability of Virginia’s rural hospitals in the midst of a global health crisis.

The resolution urges DOJ to reverse its position and instead protect the millions of people who rely on the ACA for health care coverage amid the COVID-19 pandemic that has infected more than 2.4 million Americans.

In addition to Sens. Warner, Kaine and Tester, the resolution is also backed by Sens. Jeanne Shaheen (D-NH), Joe Manchin (D-WV), Doug Jones (D-AL), Tina Smith (D-MN), Mazie Hirono (D-HI), Jack Reed (D-RI), Chris Van Hollen (D-MD), Catherine Cortez Masto (D-NV), Tammy Baldwin (D-WI), Sherrod Brown (D-OH), Michael Bennet (D-CO), Tom Carper (D-DE), Dick Blumenthal (D-CT), Ed Markey (D-MA), Dick Durbin (D-IL), Kamala Harris (D-CA), Ben Cardin (D-MD), Patty Murray (D-WA), Jacky Rosen (D-NV), Debbie Stabenow (D-MI), Chris Murphy (D-CT), Ron Wyden (D-OR), Maggie Hassan (D-NH), Gary Peters (D-MI), Amy Klobuchar (D-MN), Martin Heinrich (D-NM), Elizabeth Warren (D-MA), Kyrsten Sinema (D-AZ), Angus King (I-ME), Tom Udall (D-NM), Sheldon Whitehouse (D-RI), Bob Menendez (D-NJ), Dianne Feinstein (D-CA), Brian Schatz (D-HI), Chris Coons (D-DE), Patrick Leahy (D-VT), Bernie Sanders (I-VT), Cory Booker (D-NJ), Kirsten Gillibrand (D-NY), Jeff Merkley (D-OR), Maria Cantwell (D-WA), Bob Casey (D-PA), Tammy Duckworth (D-IL) and Chuck Schumer (D-NY).

In the Senate, Sens. Warner and Kaine have fought for expanded access to health care and have spoken out against the Trump Administration’s attempts to overturn the ACA. Last year, Sen. Warner led and Sen. Kaine joined a legislative maneuver to protect health coverage for Americans with preexisting conditions. The Senators have also demanded that the Trump Administration stop the health care sabotage that has undermined our preparedness and ability to respond to COVID-19. Recently, Sen. Warner penned an op-ed sounding the alarm of the devastating effects the health and economic crisis caused by COVID-19 has had on record high uninsured rates across the country.  

The full text of the resolution is available here.

###

WASHINGTON – After the Trump Administration filed its brief in the Texas v US lawsuit to strike down the Affordable Care Act (ACA), U.S. Sen. Mark R. Warner (D-VA) released the following statement blasting the Trump Administration for its efforts to take away health care coverage for more than 23 million Americans who receive health care coverage through the ACA marketplaces and sabotage protections for more than 3 million Virginians living with a preexisting condition in the middle of a health pandemic: 

“The President has completely failed to contain the virus, and now he is asking the Supreme Court to make the consequences as painful as possible for millions of Americans.  

“The Trump Administration's lawsuit would kick millions of Americans off their insurance and end protections for preexisting conditions in the middle of a pandemic. This deadly mixture of cruelty and Presidential incompetence puts the lives of countless Americans at risk.

Since taking office, President Trump has sought to undermine the success of the Affordable Care Act, which protects more than 3 million Virginians with preexisting conditions like COVID-19, diabetes, asthma, or cancer from discrimination or being kicked off of their insurance. In the Senate, Sen. Warner has been a longtime champion of access to health care, and has been outspoken about the Trump Administration’s efforts to overturn the Affordable Care Act in court. Last year, Sen. Warner led the entire Senate Democratic Caucus in a legislative maneuver to protect health coverage for Americans with preexisting conditions from the Trump Administration’s attempts to undermine those safeguards. Amid the coronavirus health crisis, Sen. Warner has been a fierce advocate in demanding that the Trump Administration stop its health care sabotage that has undermined our preparedness for and ability to respond to COVID-19. Recently, Sen. Warner penned an op-ed sounding the alarm of the devastating effects the health and economic crisis caused by COVID-19 has had on record high uninsured rates across the country. 

###

WASHINGTON, D.C. – U.S. Senators Mark R. Warner and Tim Kaine (both D-VA) joined Senators Brian Schatz (D-HI) and Roger Wicker (R-MS) in calling for the expansion of access to telehealth services during the COVID-19 pandemic to be made permanent. Provisions from the CONNECT for Health Act, legislation cosponsored by Senators Warner and Kaine, that have allowed Medicare beneficiaries in all areas of the country to utilize telehealth services from home, as well as more types of health care providers to provide telehealth, were included in previous COVID-19 legislation. However, without urgent congressional action to make these measures permanent, these telehealth services are at risk of expiring when the pandemic ends.  

“Americans have benefited significantly from this expansion of telehealth and have come to rely on its availability,” the Senators wrote in a letter to Senator Majority Leader Mitch McConnell (R-KY) and Senate Minority Leader Chuck Schumer (D-NY). “Congress should expand access to telehealth services on a permanent basis so that telehealth remains an option for all Medicare beneficiaries both now and after the pandemic. Doing so would assure patients that their care will not be interrupted when the pandemic ends. It would also provide certainty to health care providers that the costs to prepare for and use telehealth would be a sound long-term investment.” 

In their letter, the Senators highlight the growing use and benefits of telehealth during the ongoing coronavirus pandemic, as patients seek to avoid traveling to hospitals and other providers and instead receive care at home. New data shows that the number of Medicare beneficiaries using telehealth services increased by 11,718 percent in just a month and a half during the pandemic.

The full text of the letter is below and available here. 

Dear Majority Leader McConnell and Minority Leader Schumer:

As you continue your work on critical legislation to respond to the COVID-19 crisis, we write to ask that you make permanent the provisions from our bipartisan CONNECT for Health Act that were included in previous COVID-19 legislation.  These provisions have resulted in an important expansion of access to telehealth services for Medicare beneficiaries during the pandemic. 

We have long advocated for increasing access to telehealth because of its potential to expand access to health care, reduce costs, and improve health outcomes.  Telehealth has proven to be pivotal for many patients during the current pandemic, ensuring they receive the care they need while reducing the risk of infection and the further spread of COVID-19.  We have all heard from our constituents about how effective and convenient it is.  Expanded Medicare coverage of telehealth services on a permanent basis—where clinically appropriate and with appropriate guardrails and beneficiary protections in place—would ensure that telehealth continues to be an option for all Medicare beneficiaries after the pandemic ends.

As you know, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and the Coronavirus Aid Relief and Economic Security Act included provisions from the CONNECT for Health Act to increase access to telehealth services for Medicare beneficiaries during the COVID-19 pandemic.  Specifically, these laws provide the Secretary of Health and Human Services the authority to waive telehealth requirements under Section 1834(m) of the Social Security Act, allow Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) to provide distant site telehealth services, and allow for the use of telehealth to conduct the face-to-face visit required to recertify a patient’s eligibility for hospice care. 

Because of these new authorities provided by Congress, Medicare has expanded coverage of telehealth services for the duration of the pandemic to include all areas of the country—as well as allowing a patient’s home to serve as an originating site for telehealth.  In addition, more types of health care providers—including FQHCs and RHCs that provide primary care in rural and underserved areas—are able to furnish and bill Medicare for telehealth services.  These changes have already contributed to a dramatic increase in the use of telehealth services in Medicare.  Available data show that the number of Medicare beneficiaries using telehealth services during the pandemic increased 11,718 percent in just a month and a half.

Americans have benefited significantly from this expansion of telehealth and have come to rely on its availability.  Congress should expand access to telehealth services on a permanent basis so that telehealth remains an option for all Medicare beneficiaries both now and after the pandemic.  Doing so would assure patients that their care will not be interrupted when the pandemic ends.  It would also provide certainty to health care providers that the costs to prepare for and use telehealth would be a sound long-term investment. 

In addition, given the recent flexibilities provided by both Congress and the Centers for Medicare & Medicaid Services and the increased use of telehealth during the pandemic, we believe now is an important time to measure the impact of telehealth on Medicare.  Specifically, the federal government should collect and analyze data on the impact of telehealth on utilization, quality, health outcomes, and spending during the COVID-19 pandemic.  There is currently a scarcity of data available regarding the impact of telehealth on the Medicare program.  This data would assist Congress in crafting additional policies to improve health outcomes and use resources more effectively.

Thank you for your continued leadership during the present crisis.  We look forward to continuing to work together to increase access to telehealth.

Sincerely, 

###

WASHINGTON – Today, U.S. Sens. Mark R. Warner (D-VA), Doug Jones (D-AL), Richard J. Durbin (D-IL) and Jeanne Shaheen (D-NH), led 35 of their Senate colleagues in urging House and Senate leaders to ensure that any upcoming COVID-19 relief bill include strong provisions to expand access to quality and affordable health care coverage in the wake of this public health crisis. In their letter, the Senators called for a bipartisan effort to increase the federal government’s share of Medicaid dollars as well as reduce premiums for individuals who are eligible for coverage in the Affordable Care Act (ACA) exchanges. 

This letter follows the May 15th House passage of the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, which creates critical pathways to health care coverage by ensuring newly unemployed Americans can remain in their previously elected employer-sponsored plans, and strengthens states’ ability to provide Medicaid coverage and other key provisions.

“The COVID-19 pandemic has had an extraordinary impact on every facet of our society and resulted in tremendous job loss, financial uncertainty and reduced access to health care coverage at a time when Americans can least afford it,” wrote the Senators. “We strongly believe that an unprecedented global health crisis of this nature deserves equally unprecedented action from Congress to ensure that Americans have continued access to the health care services they need.”

“We strongly encourage Republicans and Democrats to work together to build upon efforts in the HEROES Act by further enhancing the Medicaid federal medical assistance percentages (FMAP) to ensure continued and comprehensive coverage for enrollees, sustain Medicaid programs in states that have expanded their program, incentivize additional states to expand their Medicaid programs and provide payment to states that have already expanded their Medicaid programs, but have not received their full share of enhanced payments in the past,” they continued. “Prior to the COVID-19 pandemic, an estimated 2.3 million Americans were without health care coverage because their states had not expanded Medicaid – a number that is sure to grow in the coming months. Targeting additional funding to the Medicaid expansion population could ensure health care insurance for millions of additional Americans that might otherwise not have access to it.”

According to a Kaiser Family Foundation study, nearly 27 million people could lose their employer-sponsored health insurance as a result of losing their job – adding to the existing 27 million Americans who were already uninsured prior to the COVID-19 crisis.

In their letter, the Senators also called for House and Senate leaders to secure provisions that reduce premium payments for individuals who are eligible for coverage under the Affordable Care Act (ACA) exchanges – a move that would help middle-income Americans find a quality insurance plan on the exchange and increase health care enrollment by more than 1 million Americans, according to the Commonwealth Fund

Sens. Warner, Jones, Durbin and Shaheen were joined in this letter by Sens. Thomas R. Carper (D-DE), Michael F. Bennet (D-CO), Tammy Baldwin (D-WI), Tina Smith (D-MN), Sheldon Whitehouse (D-RI), Richard Blumenthal (D-CT), Tim Kaine (D-VA), Jeffrey A. Merkley (D-OR), Margaret Wood Hassan (D-NH), Debbie Stabenow (D-MI), Christopher S. Murphy (D-CT),  Jacky Rosen (D-NV), Benjamin L. Cardin (D-MD), Robert Menendez (D-NJ), Chris Van Hollen (D-MD), Catherine Cortez Masto (D-NV), Sherrod Brown (D-OH), Angus S. King, Jr. (I-ME), Kamala D. Harris (D-CA), Jack Reed (D-RI), Robert P. Casey, Jr. (D-PA), Jon Tester (D-MT), Christopher A. Coons (D-DE), Tom Udall (D-NM), Amy Klobuchar (D-MN), Tammy Duckworth (D-WI), Cory A. Booker (D-NY), Dianne Feinstein (D-CA), Joe Manchin III (D-WV), Gary C.  Peters (D-MI), Kyrsten Sinema (D-AZ), Martin Heinrich (D-NM), Kirsten Gillibrand (D-NY), Brian Schatz (D-HI), and Mazie Hirono (D-HI). 

Throughout the COVID-19 crisis, Sen. Warner has remained a strong advocate for health coverage. In April, he led his colleagues in pressing congressional leaders to ensure that that those who have lost their employer-based benefits do not have to face this health crisis without access to health insurance. In addition, that April letter similarly urged Congressional leaders to take swift action to strengthen Medicaid coverage and reduce premium costs on the Affordable Care Act exchange. Sen. Warner has also previously joined his colleagues in releasing a plan to expand health care coverage during the COVID-19 pandemic and has introduced legislation to allow any state that expanded Medicaid after 2014 to receive the same full federal matching funds as states that expanded earlier under the terms of the Affordable Care Act.   

A copy of today’s letter is available here and below. 

 

Dear Leader McConnell, Speaker Pelosi, Leader Schumer and Leader McCarthy:

We write to reiterate the importance of ensuring that any future COVID-19 related legislation passed by Congress include strong provisions to ensure Americans have access to quality and affordable health care coverage. 

The COVID-19 pandemic has had an extraordinary impact on every facet of our society and resulted in tremendous job loss, financial uncertainty and reduced access to health care coverage at a time when Americans can least afford it. A recent report estimates that nearly 27 million people have lost their employer-sponsored health care insurance and have to find another way to get health insurance due to their job loss . This is an astounding number on its own and is even more concerning given an additional 27 million Americans were already uninsured before the COVID-19 pandemic .

We strongly believe that an unprecedented global health crisis of this nature deserves equally unprecedented action from Congress to ensure that Americans have continued access to the health care services they need. 

On Friday, May 15, 2020, the U.S. House of Representatives took an important step by passing H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act. This legislation creates critical pathways to health care coverage by providing premium reimbursement to help newly unemployed Americans continue coverage in their previously elected employer-sponsored plans. In addition, the legislation provides critical support to state Medicaid programs to ensure states can afford to cover additional individuals. We welcome these significant and much needed provisions, and hope there will be bipartisan work done to ensure that millions of additional Americans will be provided with a pathway to health care coverage. 

We strongly encourage Republicans and Democrats to work together to build upon efforts in the HEROES Act by further enhancing the Medicaid federal medical assistance percentages (FMAP) to ensure continued and comprehensive coverage for enrollees, sustain Medicaid programs in states that have expanded their program, incentivize additional states to expand their Medicaid programs and provide payment to states that have already expanded their Medicaid programs, but have not received their full share of enhanced payments in the past. Prior to the COVID-19 pandemic, an estimated 2.3 million Americans were without health care coverage because their states had not expanded Medicaid – a number that is sure to grow in the coming months . Targeting additional funding to the Medicaid expansion population could ensure health care insurance for millions of additional Americans that might otherwise not have access to it.

In addition, we ask that you add provisions to reduce premium payments for Americans eligible for coverage in the Affordable Care Act (ACA) exchanges. As you know, current law caps ACA advance premium tax credits (APTCs) at approximately 10 percent of household income for individuals earning up to 400 percent of the federal poverty line (FPL). Removing this cap and increasing subsidies will help millions more middle-income Americans to find a comprehensive and affordable plan on the health care exchange. A 2017 study found that improving the ACA’s premium assistance payments could increase health care enrollment by more than 1 million Americans.  It will also be important to bolster support from APTCs for working families and individuals who are already eligible, but will need more financial support for the cost of coverage during this public health and economic crisis.

As Americans traverse this extremely uncertain and unprecedented time – the last thing they should worry about is them or their family members going without health care coverage. We ask that you strongly consider the recommendations we have listed above and work with us to develop solutions that meet the true scope and scale of the public health emergency we face. Thank you for your consideration of this request and we look forward to working with you on these issues. 

Sincerely, 

###

WASHINGTON - U.S. Sen. Mark R. Warner (VA) joined Sens. Debbie Stabenow (MI), Roger Wicker (MS), and 38 of their colleagues in urging Congress to support community health centers that provide Americans with critical health care, including testing and treatment of COVID-19. 

“We write to express our support for additional emergency funding for community health centers in the next COVID-19 relief package. Community health centers are vital to our response to the coronavirus pandemic and need appropriate funding to continue their front-line health care work,” wrote the Senators. “Community health centers provide affordable care to more than 29 million patients, including 385,000 veterans and 8.7 million children nationwide. These centers play a critical role in responding to the pandemic, offering coronavirus testing, primary care, dental care, behavioral health care, and other services to our nation’s most vulnerable patients.” 

In the letter, the Senators asked Senator Roy Blunt (MO) and Senator Patty Murray (WA), Chairman and Ranking Member of the Senate Appropriations Committee Subcommittee on Labor-HHS-Education, to support additional emergency funding for community health centers across the country. Over 2,000 centers have already had to close their doors, and many more remain concerned about how long they will be able to stay open. 

Full text of the letter can be found here and below:  

Dear Chairman Blunt and Ranking Member Murray: 

We write to express our support for additional emergency funding for community health centers in the next COVID-19 relief package. Community health centers are vital to our response to the coronavirus pandemic and need appropriate funding to continue their front-line health care work. 

 Community health centers provide affordable care to more than 29 million patients, including 385,000 veterans and 8.7 million children nationwide.  These centers play a critical role in responding to the pandemic, offering coronavirus testing, primary care, dental care, behavioral health care, and other services to our nation’s most vulnerable patients.  This care helps keep individuals out of emergency rooms, where beds are currently in particularly high need.  It also helps manage chronic conditions that may exacerbate the symptoms of COVID-19.

Over the next six months, community health centers will see 34 million fewer appointments as Americans cancel primary and preventive care appointments or delay non-essential care.  Health centers are anticipating $7.6 billion in lost revenue and 105,000 lost jobs.  Over 2,000 centers have already had to close their doors and many more remain concerned about how long they will be able to stay open. 

We appreciate the additional $2 billion in emergency funding provided to community health centers in recent COVID-19 response and relief packages, including $600 million dedicated to testing.  However, despite this funding, health centers are still worried about how to keep their doors open to serve their patients.  These valuable providers will continue to lose more revenue as the pandemic continues.  Additional funding is critical for these centers to continue providing quality, affordable health care and front-line response efforts.  

We look forward to working with you to reach a bipartisan agreement to enact legislation and ensure community health centers can continue to provide high quality and affordable care to those in need. 

Sincerely,

 

###

WASHINGTON – Today U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) applauded $6,914,080 in federal funding through the U.S. Department of Health and Human Services (HHS) to help support health centers across the Commonwealth as they combat the COVID-19 crisis. 

“We are glad to see this funding go towards helping support these health centers as they continue to work around the clock to provide crucial care for members of the community during this pandemic,” said the Senators.  

The funding for health centers was awarded as follows:

  • $1,021,822 for Portsmouth Community Health Center
  • $1,205,773 for Eastern Shore Rural Health System
  • $2,573,599 for Central Virginia Health Services
  • $1,026,353 for Southwest Virginia Community Health Systems
  • $1,086,533 for Piedmont Access to Health Services (PATHS)

This funding was awarded through the Health Resources and Services Administration’s Health Center Program, which provides funds to community-based health care providers that provide primary care services in underserved areas. These health centers must meet a stringent set of requirements, including providing care on a sliding fee scale based on ability to pay and operating under a governing board that includes patients.

Additionally, $2,648,079 was awarded to the Virginia Hospital & Healthcare Association for COVID-19 preparedness and response activities. This funding was awarded through HHS’ Hospital Preparedness Program (HPP), which seeks to promote a consistent national focus to improve patient outcomes during emergencies and disasters and enable rapid recovery.

###

 

WASHINGTON, D.C. – Today, U.S. Senators Mark R. Warner and Tim Kaine joined Senator Maggie Hassan and 14 of their colleagues in calling on the Centers for Disease Control and Prevention (CDC) to address the declining rate of routine child immunizations for measles and other dangerous viruses amid the COVID-19 pandemic.

“The administration of routine pediatric immunizations remains critical throughout the duration of this public health emergency,” wrote the Senators. “The decline in immunizations is largely attributable to efforts by families to adhere to social distancing guidelines to reduce both their exposure to, and the spread of COVID-19. But if this trend ofdecreased immunization rates among children continues, the United States could face yet another public health crisis: increased risk of outbreaks of vaccine-preventable diseases.”

The Senators continued, “Such outbreaks would put lives at risk, and place additional stress on our health care system and public health infrastructure at a time when these systems are struggling to respond to the COVID-19 pandemic.”

The Senators called for CDC to develop and execute a comprehensive plan to address the decline in immunization rates, including measures such as increased public outreach and education and best practices for parents and families to visit doctors while limiting their risk of contracting COVID-19. The Senators also asked for details on what CDC is doing to ensure sufficient supply of immunization doses and medical devices to administer them.

In addition to Senators Warner, Kaine, and Hassan, the letter was signed by Senators Patty Murray (D-WA), Bernie Sanders (I-VT), Jeff Merkley (D-OR), Tammy Baldwin (D-WI), Bob Casey (D-PA), Chris Van Hollen (D-MD), Mazie Hirono (D-HI), Richard Blumenthal (D-CT), Tina Smith (D-MN), Jacky Rosen (D-NV), Elizabeth Warren (D-MA), Amy Klobuchar (D-MN), Jack Reed (D-RI), and Doug Jones (D-AL).

Read the Senators’ full letter here or below. 

 

Dear Dr. Redfield,

We write to express significant concern regarding the recent decline in routine childhood immunization rates in the United States during the novel coronavirus (COVID-19) pandemic, and urge you to take immediate action to encourage and support routine pediatric immunizations through the duration of the COVID-19 pandemic.

According to recent data published by the Centers for Disease Control and Prevention (CDC), a decline in provider orders for non-influenza childhood vaccines, and measles-containing vaccines including the measles-mumps-rubella (MMR) vaccine, began one week after President Trump declared a national emergency on March 13, 2020 due to the COVID-19 pandemic. [1] In May, the Michigan Care Improvement Registry found a drastic decrease in vaccination rates among children across nearly every age group. The percentage of children five months and younger who remain up-to-date on recommended vaccines declined from 67.9 percent in 2019, to 49.7 percent in May 2020.[2] The New York City health department reported a 63 percent drop in the number of vaccine doses administered to children between March 23 and May 9, including a 91 percent drop for children ages 2 and above.[3]

The administration of routine pediatric immunizations remains critical throughout the duration of this public health emergency. The decline in immunizations is largely attributable to efforts by families to adhere to social distancing guidelines to reduce both their exposure to, and the spread of COVID-19. But if this trend of decreased immunization rates among children continues, the United States could face yet another public health crisis: increased risk of outbreaks of vaccine-preventable diseases. Such outbreaks would put lives at risk, and place additional stress on our health care system and public health infrastructure at a time when these systems are struggling to respond to the COVID-19 pandemic.

To avoid this potential crisis, we urge the CDC to immediately develop an action plan that incorporates targeted public outreach and education efforts on addressing vaccine hesitancy and emphasizing the importance of pediatric immunizations; resources for communities that have seen reductions in their immunization rates since the start of the COVID-19 pandemic; and guidance for parents and families on how to safely access pediatric immunizations during the COVID-19 pandemic, including best practices regarding personal protective equipment (PPE) use and other precautions to limit the risk of exposure to COVID-19 in health care settings; and necessary efforts to ensure rapid catch-up for children who are not up to date on critical pediatric vaccines.

In addition to developing the plans described above, we request that you respond to the following questions no later than July 1, 2020 to help us better understand how the federal government is working to address the alarming drop in pediatric immunization rates:

  1. What specific steps is CDC taking to reverse the dramatic drop in vaccinations since mid-March?
    1. How does CDC plan to capture accurate real-time data on pediatric immunization rates and identify potential solutions, particularly in vulnerable communities?
  1. What outreach and education efforts are underway at CDC to address fears among parents and families related to bringing children into health care settings during the COVID-19 crisis? 
    1. Is CDC planning a public information campaign to address vaccine hesitancy, and if so, how will CDC ensure that the necessary communication on the importance of routine immunizations is reaching parents and families?
    1. How will CDC ensure that families receive guidance on safe access to care for children during the COVID-19 pandemic, including the appropriate use of PPE?
    1. How will CDC communicate with health care workers, and provide the necessary tools to inform communities about the importance of receiving pediatric immunizations during the COVID-19 pandemic? 
    1. What guidance is CDC providing to pediatricians and other health care workers on procedures to ensure that they can safely provide and promote routine pediatric immunizations?
    1. Given the significant increase in unemployment due to COVID-19, many families are finding themselves uninsured. How will CDC raise awareness of the Vaccines for Children (VFC) program to ensure that families know their children can still access routine immunizations, and how does CDC plan to support participating VFC providers as they work to catch up VFC-eligible children on missed vaccinations, while also preparing for the upcoming flu season?
  1. How will CDC monitor the ongoing availability and ordering of pediatric immunizations, including doses and other essential medical devices, PPE, and other supplies needed to store, transport and administer vaccines, and what plans are in place to address any supply chain disruptions?
    1. Is CDC taking steps now to ensure that the availability of pediatric immunizations, and necessary medical devices and supplies, is not impacted when production and domestic distribution of a COVID-19 vaccine is underway?
  1. Has CDC developed or reviewed modeling or projections that predict the potential impact on future vaccine-preventable outbreaks if the current pediatric immunization rate continues throughout the duration of the COVID-19 pandemic? 
  1. Does CDC require additional resources from Congress in order to support efforts to reverse the decline in pediatric immunizations? If so, what level of funding would be sufficient?

We appreciate your timely response and look forward to working with you on this critical issue.

###

WASHINGTON - Today, U.S. Sen. Mark R. Warner (D-VA) joined Sens. Jeanne Shaheen (D-NH), Tina Smith (D-MN), Ron Wyden (D-OR) and Patty Murray (D-WA) in releasing a Senate Democratic plan to expand health care coverage and affordability during the COVID-19 pandemic. In a white paper, the senators outline a series of common sense legislative priorities that the Senate should take up immediately, including expanding premium support through subsidies and tax credits, incentivizing Medicaid expansion in hold-out states, and a special open enrollment period. Their proposal also calls for all COVID-19 treatment costs to be covered, including for the uninsured.

“Access to health care has never been more important,” said Senator Shaheen. “As our country faces the worst public health crisis in a century, millions are facing furloughs and job losses that make affordable health care coverage an even greater struggle. Americans are sick and tired of the partisan excuses for why health care can’t be more affordable and accessible. There is absolutely no reason why Republicans can’t join Democrats to get this done. This crisis demands bipartisan cooperation – the American people will accept nothing less.” 

“We need to rise to the challenge of solving America’s health care coverage and affordability problems, which have only been exacerbated by the pandemic,” said Senator Smith. “This plan will help more people access comprehensive health care coverage, and at a more affordable cost. We need to move this plan forward because these investments are critical—especially at a time when millions of Americans are on furlough or have lost their jobs."

“Families across the nation are struggling with the economic consequences of the pandemic, and that includes disruption to their health care access,” Senator Wyden said. “The last thing Americans need right now is to face questions about where they will get health care if they get sick. This proposal outlines practical steps that Congress could pass immediately and give families peace of mind during the pandemic.”

“For families in need, access to quality, affordable health care isn’t a partisan issue—it’s a life and death one. It shouldn’t take a historic global pandemic for Republicans to understand that, but for them to continue ignoring the health care needs of families in the middle of this crisis would be truly inexcusable,” said Senator Murray. “The absolute least we can do in the middle of an unprecedented public health crisis is help people get the health care they need—and Republicans have no excuse to continue playing politics or dragging their feet on getting these common-sense steps done. We need to act now.”

A brief overview of the policies included in the proposal:

·       Cover all costs for COVID-19 treatment, including for the uninsured;

·       Deliver subsidies for the cost of COBRA premiums for the newly unemployed;

·       Expand and increase access to premium tax credits that help families afford monthly premiums;

·       Incentivize Medicaid expansion in remaining states that have not yet expanded;

·       Establish a federal special enrollment period;

·       Ban the sale of junk plans;  

·       Restore funding for marketplace outreach and enrollment support;

In addition to Sen. Warner, the proposal is also supported by Sens. Debbie Stabenow (D-MI), Chris Van Hollen (D-MD), Michael Bennet (D-CO), Tom Carper (D-DE), Richard J. Durbin (D-IL), Maggie Hassan (D-NH), Sherrod Brown (D-OH), Richard Blumenthal (D-CT), Senate Minority Leader Charles Schumer (D-NY), Sheldon Whitehouse (D-RI), Dianne Feinstein (D-CA), Ben Cardin (D-MD), Patrick Leahy (D-VT), Tim Kaine (D-VA), Jack Reed (D-RI), Jacky Rosen (D-NV), Jeff Merkley (D-OR), Kamala Harris (D-CA), Robert Menendez (D-NJ), Tammy Baldwin (D-WI), Bob Casey (D-PA), Amy Klobuchar (D-MN), Tammy Duckworth (D-IL), Martin Heinrich (D-NM), Chris Coons (D-DE), Doug Jones (D-AL), Tom Udall (D-NM) and Catherine Cortez Masto (D-NV).

The proposal can be read in full here. 

###

WASHINGTON — U.S. Sen. Mark R. Warner (D-Va.) joined Sens. Chris Coons (D-Del.), Susan Collins (R-Maine) and nine of their colleagues on a bipartisan letter to Senate Leadership encouraging additional support for first responders in the next COVID-19 relief package. 

In addition to Sens. Warner, Coons and Collins, the letter was joined by Senators Tom Carper (D-Del.), Dick Durbin (D-Ill.), Richard Blumenthal (D-Conn.), Angus King (I-Maine), Jon Tester (D-Mont.), Chris Van Hollen (D-Md.), Ron Wyden (D-Ore.), Bob Casey (D-Pa.), and Amy Klobuchar (D-Minn.). 

The lawmakers detailed the following priorities for first responders:

  • Bolster Assistance to Firefighter Grant, Staffing for Adequate Fire and Emergency Response (SAFER), and Department of Justice grant funding, including for the Community Oriented Policing Services program, so that state and local police, fire, and EMS departments can access resources to purchase and be reimbursed for PPE and other COVID-19 related expenses, recruit and retain employees and volunteers, and cover overtime, backfill costs, authorized hazard pay, and COVID-19-related paid sick leave during the crisis.
  • Require that the Secretary of the Department of Homeland Security waive the cost share and maintenance of expenditure requirements for Assistance to Firefighter Grants for reimbursement of COVID-19-related expenses through FY21. 
  • Require that the Secretary of the Department of Homeland Security grant waivers to SAFER grant recipients for employee retention to aid staffing shortages through FY21.  In addition, any legislation should retroactively require that the Secretary grant such waivers for FY19 and FY20 SAFER funds. 
  • Waive the prohibition on hazard pay for federal firefighters under 5 U.S.C. §?5545b(d)(1) for purposes of COVID-19 response, provide funding to federal agencies sufficient to cover hazard pay to frontline federal firefighters and law enforcement officers when appropriate, extend overtime pay to U.S. Probation Officers, and waive the federal firefighter and law enforcement officer overtime cap under 5 U.S.C. §?5547.
  • Address the gap in paid sick leave coverage for first responders by requiring that the employing agency, not the employee, provide up to 80 hours of paid sick leave should these departments order the employee to self-quarantine in accordance with Centers for Disease Control and Prevention guidelines due to potential COVID-19 exposure.
  • Create a presumption in the Public Safety Officers’ Benefits Program that a public safety officer’s infection of COVID-19 resulted from their employment to clearly establish eligibility for benefits due to the pandemic.
  • Prevent the taxation of state and local incentives for volunteer firefighters and EMS personnel beyond 2020 in order to help departments continue to recruit and retain volunteer personnel.

The lawmakers’ effort is supported by the Fraternal Order of Police, the National Association of Police Organizations, the Federal Law Enforcement Officers Association, the International Association of Fire Fighters, the National Volunteer Fire Council, and the Congressional Fire Services Institute.

The full text of the letter is available here and below. 

 

Dear Leader McConnell and Leader Schumer: 

We appreciate your work to provide support for our nation’s police officers, firefighters, and emergency medical services (EMS) personnel in the Coronavirus Aid, Relief, and Economic Security Act.  However, additional assistance is needed during this crisis.  As Congress considers further legislation in response to the COVID-19 pandemic, we urge you to include additional support for our nation’s first responders who work in some of the highest risk occupations for COVID-19 exposure.[i]  First responders are routinely in physical contact with potentially infected persons and are facing unprecedented volumes of dispatch calls in severely impacted areas.[ii]

A short supply of personal protective equipment (PPE) for first responders to guard against disease exposure has left many police officers, firefighters, and EMS personnel exposed to the dangers of this crisis.  This has resulted in too many first responders across our nation contracting COVID-19 and being forced to self-quarantine, which has led to staffing shortages.[iii]  As of April 1, more than 1,400 New York City Police Department employees have contracted COVID-19, with 6,100 in total in quarantine, and 282 New York City Fire Department employees have contracted COVID-19, with 950 in total in quarantine.[iv]  While New York City is the current epicenter of the U.S. outbreak, many other cities and states with developing outbreaks such as New Jersey, Florida, Detroit, Seattle, Washington D.C., and several additional states and cities across the nation[v] have reported a significant number of first responders contracting COVID-19 or requiring self-quarantine.

As this outbreak continues, many more first responders will undoubtedly contract COVID-19 or be forced to self-quarantine.  To support our nation’s police officers, firefighters, and EMS personnel serving on the front lines of this pandemic, we urge action on the below items.  

  • Bolster Assistance to Firefighter Grant, Staffing for Adequate Fire and Emergency Response (SAFER), and Department of Justice grant funding, including for the Community Oriented Policing Services program, so that state and local police, fire, and EMS departments can access resources to purchase and be reimbursed for PPE and other COVID-19 related expenses, recruit and retain employees and volunteers, and cover overtime, backfill costs, authorized hazard pay, and COVID-19-related paid sick leave during the crisis.
  • Require that the Secretary of the Department of Homeland Security waive the cost share and maintenance of expenditure requirements for Assistance to Firefighter Grants for reimbursement of COVID-19-related expenses through FY21. 
  • Require that the Secretary of the Department of Homeland Security grant waivers to SAFER grant recipients for employee retention to aid staffing shortages through FY21.  In addition, any legislation should retroactively require that the Secretary grant such waivers for FY19 and FY20 SAFER funds. 
  • Waive the prohibition on hazard pay for federal firefighters under 5 U.S.C. §?5545b(d)(1) for purposes of COVID-19 response, provide funding to federal agencies sufficient to cover hazard pay to frontline federal firefighters and law enforcement officers when appropriate, extend overtime pay to U.S. Probation Officers, and waive the federal firefighter and law enforcement officer overtime cap under 5 U.S.C. §?5547.
  • Address the gap in paid sick leave coverage for first responders by requiring that the employing agency, not the employee, provide up to 80 hours of paid sick leave should these departments order the employee to self-quarantine in accordance with Centers for Disease Control and Prevention guidelines due to potential COVID-19 exposure.
  • Create a presumption in the Public Safety Officers’ Benefits Program that a public safety officer’s infection of COVID-19 resulted from their employment to clearly establish eligibility for benefits due to the pandemic.
  • Prevent the taxation of state and local incentives for volunteer firefighters and EMS personnel beyond 2020 in order to help departments continue to recruit and retain volunteer personnel. 

During a time of crisis, communities rely on local first responders as the first line of defense for protection and emergency response.  As you continue to develop further legislation in response to the COVID-19 pandemic, we urge you to include the above items so that our nation’s first responders can operate at full capacity as we fight the COVID-19 pandemic. 

Sincerely, 

###

WASHINGTON – U.S. Sens. Mark R. Warner (D-VA) and Lamar Alexander (R-TN) introduced bipartisan legislation to ensure rural hospitals in Virginia can keep up with the cost of providing care amid the novel coronavirus (COVID-19) outbreak. The Fair Medicare Hospital Payments Act would help curb the trend of hospital closures in rural areas by making sure hospitals are fairly reimbursed for their services by the federal government. This legislation comes at a crucial time as hospitals in Virginia continue to lose needed revenue despite playing an essential role in serving their communities and providing lifesaving care during the biggest public health crisis in a century.

“The current payment policy has long placed some of Virginia’s most rural hospitals at a disadvantage and made it more difficult to provide quality care in communities that need it most,” said Sen. Warner. “The COVID-19 public health emergency has made it more important than ever to do everything we can to support our rural hospitals and this legislation is absolutely critical in doing that.” 

“Last year, the Trump Administration updated the formula that determines how much Medicare will reimburse hospitals for patient care, taking into account, among other things, the cost of labor in that geographic area – called the Medicare Area Wage Index. And because of this change, Alan Levine, who leads Ballad, announced a $10 million investment in pay increases to nurses. However, these changes are temporary and will expire in three years, and many hospitals are concerned that hospital reimbursements could revert to the lower rates,” said Sen. Alexander. “Given COVID-19 impacts on rural hospitals, any changes that lower reimbursement would have significant impact. Tennessee has the second highest rate of hospitals closures in the country, with 13 hospitals having closed since 2010, and this is, in large part, due to lower reimbursements. This legislation will help keep up with the cost of providing care and help curb the trend of Tennessee rural hospital closures by setting an appropriate national minimum for the Medicare Area Wage Index.” 

The Medicare Area Wage Index, a formula used by Medicare to reimburse hospitals, is much lower for states like Virginia and Tennessee, due to the fact that the formula is based on labor costs, which vary across the country. This flawed formula often results in disproportionately low Medicare reimbursement payments to hospitals in rural and low-wage areas.

Specifically, the legislation would establish an appropriate national minimum (0.85) for the Medicare Area Wage Index and ensure that rural hospitals are paid for the care they provide, while preserving the existing reimbursements for urban hospitals. This legislation would also help ensure fairness in reimbursements for hospitals across the country – including the many hospitals that are facing closures in rural areas – and fix severe and disproportionate disadvantages that unfairly penalize hundreds of communities and hospitals across the United States.

At a minimum, 14 Virginia hospitals would benefit from this legislation, with the number of beneficiaries growing in future years. The 14 hospitals that would immediately benefit include:

Locality:

Hospital:

Buchanan County

Buchanan General Hospital

Franklin

Southampton Memorial Hospital

Galax

Twin County Regional Hospital

Halifax County

Sentara Halifax Regional Hospital

Mecklenburg County

Community Memorial Hospital

Norton

Norton Community Hospital

Pulaski County

Lewisgale Hospital Pulaski

Russell County

Russell County Hospital

Smyth County

Smyth County Community Hospital

Tazewell County

Clinch Valley Medical Center

Tazewell County

Carilion Tazewell Community Hospital

Washington County

Johnston Memorial Hospital

Wise County

Lonesome Pine Hospital

Wythe County

Wythe County Community Hospital

According to the American Hospital Association, Medicare accounts for about 43 percent of reimbursements for hospitals nationally, underscoring the role that Medicare payments play in keeping hospitals open and functioning – particularly in Virginia’s underserved and economically-struggling regions.

In addition to Sens. Warner and Alexander, the legislation was introduced by Sens. John Cornyn (R-TX), Doug Jones (D-AL), Marsha Blackburn (R-TN), Tim Kaine (D-VA), David Perdue (R-GA) and Richard Shelby (R-AL).

###

WASHINGTON – Today, U.S. Sen. Mark R. Warner (D-VA) joined Sen. Chris Van Hollen (D-MD) and seven of their Senate colleagues in urging the President to expand his use of Title III of the Defense Production Act (DPA) in order to dramatically increase domestic production capacity for personal protective equipment (PPE) and COVID-19 testing supplies. 

“An analysis by Harvard University researchers found that the United States must, at minimum and under the best-case scenario, double the number of tests being conducted each week,” wrote the Senators. “In many cases, even when state and local governments are able to get some supplies into the hands of their frontline medical personnel, they go unused because of shortages in other key supplies.” 

They continued, “Congress appropriated $57.6 billion to address critical needs such as these, including $16 billion to purchase medical supplies for distribution through the Strategic National Stockpile and at least $11 billion to support efforts to expand testing by states, localities, and tribes. But it is clear that these widespread shortages will not be fully resolved until the nation’s production capacity can be dramatically scaled up, and despite unprecedented global demand, private sector companies have been reticent to expand production capacity without support and direction from the federal government. For that reason, is imperative that the federal government fully use its authority to support and expand production of PPE and testing supplies.”

Section 301 and 302 of Title III authorize the President to reduce current or projected shortfalls of industrial resources, critical technology items, or essential materials needed for national defense purposes. Meanwhile, Section 303 gives the President the authority to create, maintain, protect, expand, or restore domestic industrial base capacity, which includes purchasing or making purchase commitments of industrial resources or critical technology items, making subsidy payments for domestically produced materials, and installing and purchasing equipment for government and privately-owned industrial facilities to expand their production capacity.

In their letter, the Senators note that Title III has only been used twice by the government to respond to this health crisis and urge the President to immediately expand production and deliveries of PPE and testing supplies by using Title III of the Defense Production Act and any other appropriate authority.

Sen. Warner has long called for an increase in testing and PPE production in the Commonwealth. In March, he joined his colleagues in introducing the Free COVID-19 Testing Act, legislation that would expand free tests to confirm coronavirus (COVID-19) infections. He has also introduced legislation to require the president to utilize all available authorities under the Defense Production Act to mobilize a federal response to the pandemic through an equitable and transparent process. Additionally, he has pressed the Administration to outline how it plans to use Defense Production Act powers to increase production of testing supplies and equipment needed for the pandemic response. 

Joining Sens. Warner and Van Hollen on the letter are Sens. Angus King (I-ME), Gary Peters (D-MI), Kamala Harris (D-CA), Mazie Hirono (D-HI, Patrick Leahy (D-VT), Debbie Stabenow (D-MI), and Jack Reed (D-RI).

The full text of the letter is available here and below.

 

Dear President Trump: 

We write in response to the release of your administration’s blueprint for State testing plans and rapid response programs to urge you to broaden your use of Title III of the Defense Production Act (DPA) and other appropriate authorities to expand domestic production capacity for personal protective equipment (PPE) and COVID-19 testing supplies.

On April 27, you announced that your administration had “successfully scaled a robust testing regime that is able to meet the massive needs of a nationwide pandemic.” On the same day, an analysis by Harvard University researchers found that the United States must, at minimum and under the best-case scenario, double the number of tests being conducted each week. Nationwide shortages continue to prevent the United States from conducting enough tests to safely reopen.

In many cases, even when state and local governments are able to get some supplies into the hands of their frontline medical personnel, they go unused because of shortages in other key supplies. In Maryland, for example, the state has secured a large number of testing kits, but the kits cannot be used without the necessary swabs and viral transport media—both of which have been in short supply.

Similarly, the nation continues to face critical shortages of PPE. This has led to dangerous rationing and efforts by medical providers to disinfect, reuse, or fashion their own equipment. Reports from across the country paint a bleak picture: staff at the Henry Ford Health System in Michigan made their own face shields using plastic sheets, elastic bands, and tongue depressors. Providence Health in Washington did the same using supplies from Home Depot. Elsewhere, medical staff are soliciting donations of homemade cloth masks and constructing makeshift decontamination systems to reuse their PPE.

Before any state in the country can reopen responsibly, PPE and testing needs must be met. Congress appropriated $57.6 billion to address critical needs such as these, including $16 billion to purchase medical supplies for distribution through the Strategic National Stockpile and at least $11 billion to support efforts to expand testing by states, localities, and tribes. But it is clear that these widespread shortages will not be fully resolved until the nation’s production capacity can be dramatically scaled up, and despite unprecedented global demand, private sector companies have been reticent to expand production capacity without support and direction from the federal government. For that reason, is imperative that the federal government fully use its authority to support and expand production of PPE and testing supplies.

Section 301 and 302 of Title III authorize you to issue loan guarantees and direct loans to reduce current or projected shortfalls of industrial resources, critical technology items, or essential materials needed for national defense purposes. Section 303 grants you a range of authorities to create, maintain, protect, expand, or restore domestic industrial base capacity. These include purchasing or making purchase commitments of industrial resources or critical technology items, making subsidy payments for domestically produced materials, and installing and purchasing equipment for government and privately owned industrial facilities to expand their production capacity. In short, these authorities allow you to provide a company the financing and equipment they need to expand their production capacity and guarantee a buyer for their products once that capacity comes online. 

As part of the CARES Act, Congress appropriated $1 billion for the primary purpose of expanding domestic production of medical supplies to respond to COVID-19. We appreciated your executive order on March 27, 2020 to delegate authority to the Secretaries of Health and Human Services and Homeland Security, allowing each to make use of DPA Title III to expand production capacity. However, to date, Title III has been used just twice as part of the government’s response to the COVID-19 pandemic. On April 11, 2020, the Department of Defense announced that it would use Title III to secure a $133 million investment resulting in the production of 39 million additional N95 masks. On April 29, DOD announced a Title III award to expand the production of swabs by Puritan Medical Supplies in Maine.

These measures are totally inadequate to meeting the challenge we face. This crisis requires faster, more coordinated action to limit loss of life in the near term and over the next year. We urge you to act immediately to expand production and deliveries of PPE and testing supplies using Title III of the Defense Production Act and any other appropriate authority.

Sincerely,

###

WASHINGTON - Following reports of escalating foreign cyber espionage and cybercrime targeting American health institutions amid the COVID-19 pandemic, U.S. Sens. Mark R. Warner (D-VA), Richard Blumenthal (D-CT), Tom Cotton (R-AR), David Perdue (R-GA), and Edward J. Markey (D-MA) called on top U.S. cybersecurity officials to take immediate steps to bolster defenses, coordinate with hospitals, and engage in deterrence against such attacks. 

The bipartisan group of Senators wrote to the Cybersecurity and Infrastructure Security Agency (CISA) and United States Cyber Command after reports that Russia, China, Iran, North Korea, and criminal groups have launched hacking campaigns targeting the U.S. health care and medical research sectors in recent weeks. These malicious campaigns included ransomware attacks hitting hospitals, disinformation about health related to COVID-19, and spying on U.S. medical response and research. 

“[O]ur country’s healthcare, public health, and research sectors are facing an unprecedented and perilous campaign of sophisticated hacking operations from state and criminal actors amid the coronavirus pandemic,” wrote the Senators in a letter to CISA Director Christopher Krebs and Cyber Command Commander Paul Nakasone. “Disinformation, disabled computers, and disrupted communications due to ransomware, denial of service attacks, and intrusions means critical lost time and diverted resources. During this moment of national crisis, the cybersecurity and digital resilience of our healthcare, public health, and research sectors are literally matters of life-or-death.”

The Senators urged the agencies to make cyber threat information public to enable better defensive efforts, as well as raise public alarm and issue statements putting adversaries on notice. The Senators also called on the agencies to provide technical assistance to help states in their cybersecurity efforts, convene stakeholders in the medical sector to make sure they have the necessary resources, and engage in deterrence actions as necessary. 

The full text of the letter is available here and copied below.

 

 

Dear Mr. Krebs and General Nakasone,

We write to raise our profound concerns that our country’s healthcare, public health, and research sectors are facing an unprecedented and perilous campaign of sophisticated hacking operations from state and criminal actors amid the coronavirus pandemic. These hacking attempts pose an alarming risk of disrupting or undermining our public health response at this time of crisis. We write to urge the Cybersecurity and Infrastructure Security Agency (CISA), in coordination with United States Cyber Command, and its partners to issue guidance to the health care sector, convene stakeholders, provide technical resources, and take necessary measures to deter our adversaries in response to these threats.

In recent weeks, Russian, Chinese, Iranian, and North Korean hacking operations have targeted the health care sector and used the coronavirus as a lure in their campaigns.  In March, the cyber security firm FireEye reported that a Chinese hacking group, APT41, carried out one of the broadest hacking campaigns from China in recent years, beginning at the onset of the pandemic.[1] According to researchers, APT41 is a sophisticated Chinese state sponsored group that specializes in espionage against healthcare, high-tech, and political interests.[2] This latest campaign sought to exploit several recent vulnerabilities in commonplace networking equipment, cloud software, and office IT management tools—the same systems that we are now more reliant on for telework and telehealth during this pandemic. Included in the new Chinese espionage campaign are the healthcare and pharmaceutical nonprofits and companies bracing to respond to the coronavirus. APT41’s campaign also appears to reflect a broader escalation from Chinese groups in recent weeks.[3]

China is not alone in exploiting the coronavirus pandemic against our interests. Russian, Iranian, and North Korean government hackers have reportedly targeted international health organizations and the public health institutions of U.S. allies.[4] Additionally, the State Department has identified disinformation operations from Russia, Iran, and China that sought to spread false information about coronavirus to undermine the nation’s response to the pandemic.[5] Unless we take forceful action to deny our adversaries success and deter them from further exploiting this crisis, we will be inviting further aggression from them and others.

The cybersecurity threat to our stretched and stressed medical and public health systems should not be ignored. Prior to the pandemic, hospitals had already struggled to defend themselves against an onslaught of ransomware and data breaches. Our hospitals are dependent on electronic health records, email, and internal networks that often heavily rely on legacy equipment. Even a minor technical issue with the email services of the Department of Health and Human Services meaningfully frustrated efforts to coordinate the federal government’s service.[6] Disinformation, disabled computers, and disrupted communications due to ransomware, denial of service attacks, and intrusions means critical lost time and diverted resources. During this moment of national crisis, the cybersecurity and digital resilience of our healthcare, public health, and research sectors are literally matters of life-or-death.

The Cybersecurity and Infrastructure Security Agency and Cyber Command are on the frontlines of our response to cybersecurity threats to our critical infrastructure. Hospitals, medical researchers, and other health institutions need the expertise and resources your agencies have developed defending against these same sophisticated threats. We urge you to take all necessary measures to protect these institutions during the coronavirus pandemic, including:           

1.)    Provide private and public cyber threat intelligence information, such as indicators of compromise (IOCs), on attacks against the healthcare, public health, and research sectors, including malware and ransomware.

2.)    Coordinate with the Department of Health and Human Services, the Federal Trade Commission, and the Federal Bureau of Investigation on efforts to increase public awareness on cyberespionage, cybercrime, and disinformation targeting employees and consumers, especially as increased telework poses new risks to companies.

3.)    Provide threat assessments, resources, and additional guidance to the National Guard Bureau to ensure that personnel supporting state public health departments and other local emergency management agencies are prepared to defend critical infrastructure from cybersecurity breaches.

4.)    Convene and consult partners in the healthcare, public health, and research sectors, including its government and private healthcare councils, on what resources and information are needed to reinforce efforts to defend healthcare IT systems, such as vulnerability detection tools and threat hunting.

5.)    Consider issuing public statements regarding hacking operations and disinformation related to the coronavirus for public awareness and to put adversaries on notice, similar to the joint statement on election inference issued on March 2nd.

6.)    Evaluate further necessary action to defend forward in order to detect and deter attempts to intrude, exploit, and interfere with the healthcare, public health, and research sectors.

 We stand ready to work with you to provide any further resources necessary in this effort. Thank you for your attention to this urgent matter.

 Sincerely,

###

 

WASHINGTON – Today, U.S. Sens. Mark R. Warner (D-VA), Tim Kaine (D-VA), Michael Bennet (D-CO), Sherrod Brown (D-OH), and Jack Reed (D-RI) sent a letter to the U.S. Department of Veterans Affairs (VA) pushing for more information regarding the personal protective equipment (PPE) available to its employees at hospitals, clinics and other facilities during the COVID-19 health crisis, as well as whether the Centers for Disease Control (CDC) guidelines are sufficient enough to protect its employees. The Senators are raising the alarm following reporting that indicates a serious shortage of PPE at VA facilities across the country, directly contradicting VA leadership’s claim that they have enough PPE at their facilities. In addition, the Senators have heard directly from their constituents who are VA facility employees concerned for their well-being while on-the-job.

“We write to request information about the use of personal protective equipment (PPE) by Department of Veterans Affairs (VA) employees at hospitals, clinics, and other facilities, and whether the VA’s guidance to its employees, based on guidelines from the Centers for Disease Control and Prevention (CDC), is sufficiently robust in safeguarding staff. With more than 1,600 positive COVID-19 cases among VA staff nationwide, and more than a dozen employee deaths, the Department must take every possible action to protect staff and veterans,” the Senators wrote in a letter to VA Secretary Robert Wilkie.

According to the VA, they have instructed their employees to adhere to the CDC guidelines, which allows for the reuse of single-use masks for multiple days, as well as the ability to disinfect and reuse those masks. However, some VA staff who are not interacting directly with COVID-19 patients are working without PPE.

“The Wall Street Journal reports that VA internal memos caution that a ‘serious shortage’ of PPE masks exists and rationing may be reduced to one mask per day for providers. Additional Wall Street Journal reporting suggests that the Department has only a two-week PPE supply and workers must use the same mask as they move from patient to patient. We have also heard from a number of our constituents who are employees at VA facilities, who think they are not being provided adequate PPE in their jobs and fear for their personal health and safety. Employees report being asked to use one N95 mask for up to a week, which manufacturers recommend be changed each shift at a minimum. These employees report that they are being asked to store surgical or procedural masks in paper bags, and that some masks begin disintegrating after too many days of use,” they continued.

In their letter, the Senators underscored the need for VA medical facility staff, as well as clinical and administrative employees, to have the appropriate PPE to protect their health and the health of the veterans they serve during the current health crisis. Following recent reporting that some VA employees are being penalized for following guidance from public health authorities, the Senators are also calling on the VA to allow flexibility for their employees by providing administrative leave if required to self-quarantine.

Additionally, the Senators requested answers to the following questions:

  • Are VA healthcare providers using the same PPE for multiple encounters with patients, even though these devices are not approved by the Food and Drug Administration for reuse?
  • How many medical facilities have instituted PPE rationing processes that require providers to use single-use PPE for multiple patients?
  • How often are employees being provided new PPE, including masks, at these facilities?
  • Are VA facilities relying on CDC guidance regarding the extended use of PPE to modify standards, ration equipment, or determine that adequate PPE supplies exist?
  • If single-use masks are used for multiple patients, what procedures are in place to protect both provider and patient health?
  • What is the maximum number of patients that providers are permitted to care for while using the same single-use PPE?
  • If sufficient essential supplies are present, do providers need to reuse single-use PPE or use PPE for extended periods?
  • If single-use PPE must be reused, what methods for decontamination and reuse are being followed?
  • Of the $14.4 billion included in the CARES Act for PPE, please provide us with a breakdown of how much has VA spent on  PPE supplies and equipment. And if additional funding is required, has Congress been explicitly notified of this need?
  • Have multiple-use face masks or other alternatives designed for routine decontamination been considered instead of single-use PPE?
  • If PPE levels are not sufficient, what is the VA’s plan to ensure large-scale national-level PPE purchases and distribution to facilities in-need?

A copy of the letter can be found here and below.

 

The Honorable Robert Wilkie

Secretary of Veterans Affairs

U.S. Department of Veterans Affairs

810 Vermont Avenue NW

Washington, D.C. 20420

Dear Secretary Wilkie: 

We write to request information about the use of personal protective equipment (PPE) by Department of Veterans Affairs (VA) employees at hospitals, clinics, and other facilities, and whether the VA’s guidance to its employees, based on guidelines from the Centers for Disease Control and Prevention (CDC), is sufficiently robust in safeguarding staff. With more than 1,600 positive COVID-19 cases among VA staff nationwide, and more than a dozen employee deaths, the Department must take every possible action to protect staff and veterans. 

We understand from media reports, as well as discussions with VA employees and leadership, that the VA is adhering to CDC guidelines, which allows for the reuse of single-use masks for multiple days, disinfecting and reusing masks, and no masks for some staff who are not interacting directly with COVID-19 patients. VA leadership has asserted that they have enough PPE at their facilities and that their employees have access to the necessary PPE, given these guidelines. We are concerned that this guidance may be driven not by best practices for VA staff and patients, but by PPE shortages throughout the system. 

The Wall Street Journal reports that VA internal memos caution that a “serious shortage” of PPE masks exists and rationing may be reduced to one mask per day for providers. Additional Wall Street Journal reporting suggests that the Department has only a two-week PPE supply and workers must use the same mask as they move from patient to patient. We have also heard from a number of our constituents who are employees at VA facilities, who think they are not being provided adequate PPE in their jobs and fear for their personal health and safety. Employees report being asked to use one N95 mask for up to a week, which manufacturers recommend be changed each shift at a minimum. These employees report that they are being asked to store surgical or procedural masks in paper bags, and that some masks begin disintegrating after too many days of use.

In addition, Government Executive recently reported that some VA medical facility staff are not permitted to wear masks. A medical support assistant was placed on absent without leave status when she stayed home with symptoms consistent with COVID-19 while waiting several weeks for test results. Upon being able to return to work she was prohibited from wearing a mask until the VA later provided one mask per week.

Ensuring that VA medical facility staff, as well as clinical and administrative employees, have the appropriate PPE to protect their health and the health of the veterans they serve is essential to countering the pandemic. Additionally, when staff take the appropriate steps to self-quarantine, VA should provide them with administrative leave and not require them to deplete their own sick leave bank.

To ensure VA staff are protected and that transparent information is available about PPE supplies, we ask that you provide a response to the following questions:

  • Are VA healthcare providers using the same PPE for multiple encounters with patients, even though these devices are not approved by the Food and Drug Administration for reuse?
  • How many medical facilities have instituted PPE rationing processes that require providers to use single-use PPE for multiple patients?
  • How often are employees being provided new PPE, including masks, at these facilities?
  • Are VA facilities relying on CDC guidance regarding the extended use of PPE to modify standards, ration equipment, or determine that adequate PPE supplies exist?
  • If single-use masks are used for multiple patients, what procedures are in place to protect both provider and patient health?
  • What is the maximum number of patients that providers are permitted to care for while using the same single-use PPE?
  • If sufficient essential supplies are present, do providers need to reuse single-use PPE or use PPE for extended periods?
  • If single-use PPE must be reused, what methods for decontamination and reuse are being followed?
  • Of the $14.4 billion included in the CARES Act for PPE, please provide us with a breakdown of how much has VA spent on  PPE supplies and equipment. And if additional funding is required, has Congress been explicitly notified of this need?
  • Have multiple-use face masks or other alternatives designed for routine decontamination been considered instead of single-use PPE?
  • If PPE levels are not sufficient, what is the VA’s plan to ensure large-scale national-level PPE purchases and distribution to facilities in-need?

We ask that you take all necessary steps to ensure that VA employees have the resources and guidance required for their safety and the safety of our veterans. We stand ready to help and appreciate your candor and consideration.   

Sincerely,

###

WASHINGTON – U.S. Sens. Mark R. Warner (D-VA) and Tim Scott (R-SC) are calling to protect at-risk Medicare beneficiaries and ensure access to potentially life-saving services by allowing for the full participation of CDC-recognized virtual suppliers in the Medicare Diabetes Prevention Program (MDPP) for at least the duration of the COVID-19 emergency.

A letter to the U.S. Department of Health and Human Services and the Centers for Medicare & Medicaid Services states in part, “We continue to strongly support permanent eligibility for these providers, who have the potential to dramatically expand access to beneficiaries in need, and we urge you to ensure their eligibility for at least the duration of the COVID-19 public health emergency. This step would both enable access for millions of eligible beneficiaries and provide key foundational data on the effectiveness and integrity of virtual programs within the MDPP. 

According to the CDC and emerging research from across the globe, older individuals and those suffering from serious medical conditions, such as diabetes, are at a higher risk of experiencing severe illness, and even death, after contracting COVID-19. While all Americans should adhere to the instructions of health professionals and practice social distancing, these directives are all the more important for at-risk populations, including those whom the MDPP aims to serve.”

Also signing the letter were Sens. Cindy Hyde-Smith (R-MS), Gary Peters (D-MI), Roger Wicker (R-MS), Jeanne Shaheen (D-NH), Kevin Cramer (R-ND), Tina Smith (D-MN), Joni Ernst (R-IA), Kyrsten Sinema (D-AZ), Shelley Moore Capito (R-WV), and Martha McSally (R-AZ).

Last year, Sens. Warner and Scott sent a letter to the agencies requesting that virtual providers be fully integrated in the MDPP expanded model, but the Administration has not yet facilitated their inclusion. CMS’s recent interim final rule with comment period (IFC) provided modest flexibilities for some existing suppliers regarding virtual make-up sessions, but these temporary changes will prove insufficient to ensure meaningful access. 

Read the letter in its entirety here and below. Also, a list of COVID-19 resources can be found here.
 

April 16, 2020 

The Honorable Alex M. Azar II
Secretary
Department of Health and Human Services
200 Independence Avenue, SW 
Washington, DC 20201 

The Honorable Seema Verma, M.P.H. Administrator
Centers for Medicare & Medicaid Services
7500 Security Boulevard 
Baltimore, MD 21244


Dear Secretary Azar and Administrator Verma: 

In light of the ongoing COVID-19 pandemic, we are writing to request that you build upon the steps taken in your recent interim final rule with comment period (IFC) by making CDC- recognized virtual Diabetes Prevention Program (DPP) providers eligible for reimbursement in the Medicare DPP (MDPP) expanded model. We continue to strongly support permanent eligibility for these providers, who have the potential to dramatically expand access to beneficiaries in need, and we urge you to ensure their eligibility for at least the duration of the COVID-19 public health emergency. This step would both enable access for millions of eligible beneficiaries and provide key foundational data on the effectiveness and integrity of virtual programs within the MDPP. 

According to the CDC and emerging research from across the globe, older individuals and those suffering from serious medical conditions, such as diabetes, are at a higher risk of experiencing severe illness, and even death, after contracting COVID-19. While all Americans should adhere to the instructions of health professionals and practice social distancing, these directives are all the more important for at-risk populations, including those whom the MDPP aims to serve. 

Even before this pandemic began to spread in the United States, many Medicare beneficiaries faced considerable access challenges that prevented them from participating in this potentially life-saving program. The COVID-19 pandemic, however, has exacerbated those gaps. In-person sessions risk life-threatening viral exposure, and yet beneficiaries cannot readily turn to virtual programs as a viable alternative, given persistent reimbursement barriers. While CMS’s recent IFC took an important step forward in recognizing the value of certain types of virtual sessions from a subsection of providers, the parameters outlined in the rule create barriers to entry for many high-quality virtual providers and potential new participants, in addition to substantially 

constraining options for beneficiaries currently participating in the program. In contrast with a number of other flexibilities included in the IFC and waivers released by CMS, which leverage innovative technological tools to improve access and care quality, the agency’s temporary policy changes for the MDPP leave significant opportunities for further development and enhancement. 

The COVID-19 public health emergency exemplifies the importance of integrating virtual health technology solutions into our healthcare system on a sustainable, long-term basis, and we will continue to work to ensure that CDC-recognized virtual providers are full participants in the MDPP expanded model. In the near term, however, we ask that you protect at-risk populations and preserve and bolster access to a proven program by allowing for robust and meaningful virtual provider reimbursement eligibility during this public health emergency. 

### 

WASHINGTON – U.S. Sen. Mark R. Warner (D-VA) joined Sen. Dick Durbin (D-IL) and 16 Senators in a letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Democratic Leader Chuck Schumer (D-NY) to ensure that any forthcoming COVID-19 legislation includes robust federal subsidies so that individuals who lose their job as a result of this pandemic can maintain their employer-sponsored health coverage. 

One option for Americans who lose their jobs, or drop below the hours necessary to be eligible for employer-sponsored health coverage, is COBRA. COBRA allows people to keep the employer-sponsored coverage that they selected for up to 18 months.  However, instead of having employers contribute to the premium costs, individuals are responsible for having to pay the full insurance premium themselves—an average of $1,700 a month for a family plan—which is often unaffordable for those newly unemployed.  In today’s letter, the Senators called on Congress to craft a bill that provides a robust federal COBRA premium subsidy for individuals who would otherwise lose their employer-sponsored coverage as a result of the COVID-19 pandemic.

“Allowing families to maintain the coverage they previously selected will help ensure continuity of care and limit disruption for both families and employers as our economy gets back on track,” the Senators wrote.  “We stand ready and eager to work with you to ensure that the next COVID-19 relief package includes this important policy, which will ensure that millions of people losing their jobs as a result of this pandemic will not also suddenly become uninsured and at risk for catastrophic health care costs.” 

In the U.S., over half of Americans receive their health coverage through their employer.  Depending on the extent of unemployment as a result of the coronavirus pandemic, between 23 to 35 million workers could end up losing their employer-based health care coverage. 

Along with Durbin, today’s letter is also signed by Senators Amy Klobuchar (D-MN), Tom Carper (D-DE), Jeanne Shaheen (D-NH), Sherrod Brown (D-OH), Jacky Rosen (D-NV), Catherine Cortez Masto (D-NV), Bob Menendez (D-NJ), Jack Reed (D-RI), Doug Jones (D-AL), Jeff Merkley (D-OR), Dianne Feinstein (D-CA), Michael Bennet (D-CO), Tammy Duckworth (D-IL), Debbie Stabenow (D-MI), Richard Blumenthal (D-CT), and Brian Schatz (D-HI). 

Full text of the letter is available here and below:

 

April 16, 2020
           
Dear Leaders McConnell and Schumer: 

Thank you for your efforts to date to ensure swift passage of multiple bipartisan pieces of legislation vital to helping our nation’s families, health care providers, and small businesses cope with the ongoing COVID-19 pandemic. Looking forward, we recognize that additional legislation will be necessary to improve the public health and America’s ailing economy. To that end, we strongly urge you to ensure that any forthcoming COVID-19 package include robust federal subsidies so that individuals can maintain on their employer-sponsored health coverage when they lose their jobs.

Over the last three weeks, approximately seventeen million people have filed unemployment claims in their state. However, this unprecedented number of filings only reflects claims filed through April 4. Many more Americans are likely out of work, or soon will be, because of the COVID-19 pandemic. Forecasters predict that as many as 20 million people could lose their jobs by the end of April. Compounding this problem is the fact that unemployment for these individuals and their families will also mean they will lose their existing employer-sponsored health insurance. 

In the U.S., over half of Americans receive their health coverage through their employer. Of the seventeen million Americans who have recently lost their jobs due to COVID-19, it is estimated that more than six million of these individuals have also lost their employer-sponsored health care. Depending on the extent of unemployment, between 23 to 35 million workers could lose their coverage.  

One option for Americans who lose their jobs, or drop below the hours necessary to be eligible for employer-sponsored health coverage, is COBRA. COBRA allows people to keep the employer-sponsored coverage that they selected for up to 18 months. However, people have to pay the full insurance premium—an average of $1,700 a month for a family plan—which is often unaffordable for those newly unemployed. Congress must step in and assist these individuals and families.

Following the 2008 financial crisis, the American Recovery and Reinvestment Act of 2009 (ARRA) was signed into law, which made COBRA continuation coverage more affordable and accessible to those who unexpectedly became unemployed. The law offered a 65 percent COBRA premium subsidy to individuals from September 1, 2008 to May 31, 2010. While well-intentioned and helpful to some, many individuals were unable to participate in the program because the remaining 35 percent insurance costs were still too expensive for them to cover.

We have heard from our constituents, as we know you have too. They are in dire economic circumstances. Despite government relief—in the form of extending monthly bill deadlines and increasing unemployment insurance—it will not be enough for most Americans to continue affording the health insurance policy they and their families elected through their employer’s plan. Allowing families to maintain the coverage they previously selected will help ensure continuity of care and limit disruption for both families and employers as our economy gets back on track. In order to provide our constituents adequate relief and to improve upon ARRA’s COBRA provision, we believe Congress must craft a bill that provides a robust federal COBRA premium subsidy for individuals who would otherwise lose their employer-sponsored coverage as a result of the COVID-19 pandemic.

We stand ready and eager to work with you to ensure that the next COVID-19 relief package includes this important policy, which will ensure that millions of people losing their jobs as a result of this pandemic will not also suddenly become uninsured and at risk for catastrophic health care costs. 

Sincerely,

###

WASHINGTON – Following concerns about worker safety in Virginia, U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) joined Senator Tammy Baldwin and 32 of their Senate colleagues in a letter to Senate Majority Leader Mitch McConnell and Democratic Leader Chuck Schumer calling for any future coronavirus response legislation to include a requirement that the Occupational Safety and Health Administration (OSHA) issue an Emergency TemporaryStandard (ETS) to guarantee protections for all essential workers.

“We write to request that any future COVID-19 pandemic legislation include language that ensures proper training and protection for workers on the front lines fighting this virus, and those working to provide the essential supplies and services for all of us during these unprecedented times.  The single best way to do this is to require the Occupational Safety and Health Administration (OSHA) to issue an Emergency Temporary Standard (ETS) requiring employers to develop and implement a comprehensive plan to protect their workers.  We feel strongly that employees need enforceable standards in place to be safe at work and for those they serve to be safe as well,” wrote the Senators in their letter to Senate leadership.

An ETS from OSHA would require all employers nationwide to implement a comprehensive plan to ensure proper training and protections for those workers who must continue going to work during the pandemic, including with personal protective equipment and access to hand sanitizer or adequate facilities to wash their hands.

“Millions of Americans are bravely going to work every day, helping in the direct response to COVID-19 and providing essential services to keep our country running. These frontline workers are doctors, nurses, and health care staff in our hospitals, emergency responders, grocery store workers, farmworkers, meat and poultry processing plant workers, construction workers, transit workers, and many more,” the Senators wrote. “Many of these workers are working shoulder to shoulder yet lack necessary personal protective equipment (PPE), access to hand sanitizer, or the facilities to wash their hands with warm water and soap as recommended by the Centers for Disease Control and Prevention (CDC). We feel strongly that the federal government has an obligation to protect employees during this public health emergency. There is a current lack of consistency surrounding the monitoring of symptoms, sanitation practices, social distancing, personal protective equipment standards, and communication requirements that must be addressed.”

The Senators highlighted the fact that the United Food and Commercial Workers union—which represents 1.3 million retail, food package/processing, and grocery workers—is reporting that at least 30 grocery store workers have died, and at least 3,000 have symptoms or have been exposed to COVID-19.  Major meat processing companies such JBS USA in Colorado, Smithfield Foods in South Dakota, and Tysons Food Inc. in Iowa have temporarily shut down certain operations due to COVID-19 cases among employees and concerns that it may spread.

In addition to Warner, Kaine, and Baldwin, the letter was signed by Senators Tammy Duckworth (D-IL), Patty Murray (D-WA), Richard J. Durbin (D-IL), Richard Blumenthal (D-CT), Edward J. Markey (D-MA), Sherrod Brown (D-OH), Jack Reed (D-RI), Cory A. Booker (D-NJ), Robert Menendez (D-NJ), Chris Van Hollen (D-MD), Amy Klobuchar (D-MN), Robert P. Casey, Jr. (D-PA), Benjamin L. Cardin (D-MD), Elizabeth Warren (D-MA), Thomas R. Carper (D-DE), Dianne Feinstein (D-CA), Sheldon Whitehouse (D-RI), Ron Wyden (D-OR), Catherine Cortez Masto (D-NV), Kamala D. Harris (D-CA), Angus S. King, Jr. (D-ME), Jeffrey A. Merkley (D-OR), Tina Smith (D-MN), Bernard Sanders (I-VT), Kirsten Gillibrand (D-NY), Jacky Rosen (D-NV), Michael F. Bennet (D-CO), Jeanne Shaheen (D-NH), Mazie Hirono (D-HI), Maggie Hassan (D-NH), Chris Murphy (D-CT), and Gary Peters (D-MI).

The full letter is available here.

###

WASHINGTON - U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) joined Sen. Elizabeth Warren to introduce the bicameral Equitable Data Collection and Disclosure on COVID-19 Act. The bill would require the Department of Health and Human Services (HHS) to collect and report racial and other demographic data on COVID-19 testing, treatment, and fatality rates, and provide a summary of the final statistics and a report to Congress within 60 days after the end of the public health emergency. It would require HHS to use all available surveillance systems to post daily updates on the CDC website showing data on testing, treatment, and fatalities, disaggregated by race, ethnicity, sex, age, socioeconomic status, disability status, county, and other demographic information. 

The legislation comes as reports across the United States point to stark racial disparities in COVID-19 cases and fatalities. In Michigan, Black residents account for 33% of confirmed COVID cases and 40% of fatalities, despite making up only 14% of the state’s population.  In Louisiana, 70% of those who have died from COVID-19 so far are Black, compared with 32% of the state’s population. Initial data from Boston shows that among people whose race was reported, more than 40% of people infected were Black, compared with only 25% of the population.

“It’s deeply troubling that the coronavirus is disproportionately impacting communities of color. It’s imperative that we get data to help us understand the scope of this crisis and take action to reduce racial disparities,” the Senators said.

Specifically, the Equitable Data Collection and Disclosure on COVID-19 Act would require the reporting of the following data disaggregated by race, ethnicity, sex, age, socioeconomic status, disability status, county, and other demographic information:

  • Data related to COVID-19 testing, including the number of individuals tested and the number of tests that were positive.
  • Data related to treatment for COVID-19, including hospitalizations and intensive care unit admissions and duration;
  • Data related to COVID-19 outcomes, including fatalities.

The legislation would also authorize $50 million in funding for the CDC, state public health agencies, the Indian Health Service, and other agencies to improve their data collection infrastructure and create an inter-agency commission to make recommendations on improving data collection and transparency and responding equitably to this crisis. 

The Equitable Data Collection and Disclosure on COVID-19 Act is endorsed by the National Urban League, Lawyer’s Committee on Civil Rights, Asian & Pacific Islander American Health Forum and National Action Network. In the House, the legislation is being introduced by Representative Ayanna Pressley (D-MA-07), Chair of the Congressional Black Caucus Health Braintrust Representative Robin Kelly (D-IL-02), Chair of the Congressional Black Caucus Representative Karen Bass (D-CA-37), Representative Barbara Lee (D- CA-13), and is co-sponsored by 80 of their colleagues. 

Warner and Kaine also joined their colleagues in sending a letter to Vice President Pence regarding the racial health disparities among COVID-19 patients. The letter highlights racial disparities in the mortality rate of the virus, calls for disaggregated racial data in COVID-19 case reporting, asks the Administration for more information on its outreach to minority communities, and requests that COVID-19 vaccine and drug trials include diverse participants. 

###

WASHINGTON – U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) joined Sen. Tina Smith (D-MN) and 43 other Senators in calling on the Coronavirus Task Force and the Federal Emergency Management Agency (FEMA) to conduct a national inventory of the coronavirus (COVID-19) diagnostic testing supply, publicly release data on testing results, and provide a detailed plan and timeline for addressing future shortages and gaps in the testing supply chain.

“Over three weeks after President Trump declared the COVID-19 outbreak a national emergency, we continue to hear from our states and Tribal Nations about the lack of supplies and testing kits to diagnose our constituents for the coronavirus,” wrote the Senators. “State departments of health, hospitals, health care providers, and first responders lack the tests and equipment—including personal protective equipment (PPE), testing swabs, and reagents—needed to conduct adequate public health surveillance to contain and stop the spread of coronavirus.

“Widespread diagnostic testing is crucial to controlling the COVID-19 outbreak. In the short term, quickly obtaining test results for hospitalized patients allows hospitals to preserve supplies of PPE and prevents unnecessary quarantines of front-line health care workers and first responders. In the long run, experts have argued that widespread testing will be needed to track and contain COVID-19 cases, allowing communities to slowly lift general social distancing restrictions without putting the public at risk.” 

They continued, “We urge you to promptly develop a national, real-time, public-facing inventory of COVID-19 diagnostic tests and results. This resource will provide the transparency that our states and Tribal Nations need to anticipate the national testing supply chain and the information that the federal government needs to anticipate and proactively address any testing shortages.”

In their letter, the Senators also requested answers to the following series of questions:

  1. How many COVID-19 diagnostic tests are available on a daily basis, and to which states and Tribes are manufacturers sending these tests? How many of these tests screen for coronavirus antibodies?
  2. To which public health, academic, and commercial laboratories are COVID-19 diagnostic test manufacturers sending tests, and how many tests are being sent to these labs?
  3. Which laboratories—public health, academic, and commercial—can run COVID-19 diagnostic tests, and what is their daily capacity to run these tests? Please provide a breakdown of this information by lab type, test type, and state if possible.
  4. What is the wait time for laboratories to process and receive results for COVID-19 tests?  Do providers have to wait minutes, hours, or days to receive their patients’ results?
  5. What supplies do America’s public health, academic, and commercial laboratories need on hand to run at full capacity to process COVID-19 tests? Which of these supplies are in shortage, and what steps is the Administration taking to expand the capacity of these supplies?
  6. In a March 10 interview, Secretary Azar referenced an “IT reporting system… to keep track of how many we’re testing.” What is the status of this system? What information is tracked in this system?
  7. Will the Task Force commit to making all collected information about testing capacity and volume publicly available with daily updates, and to release relevant information on testing results?
  8. Which federal agency is managing the supply chain and distribution of tests and testing supplies to states, territories, and Indian Tribes?  Which official is leading the testing supply and distribution effort within that agency?

A copy of the letter is available here or below:

Vice President Michael Pence

The White House

1600 Pennsylvania Avenue N.W.

Washington, D.C. 20050                

Dear Vice President Pence:

We write to urge the Coronavirus Task Force to direct the Department of Health and Human Services (HHS) and the Federal Emergency Management Agency (FEMA) to conduct a national inventory of the country’s COVID-19 diagnostic test supply, publicly release comprehensive data on testing results, and provide a detailed plan and timeline for addressing future shortages and gaps in the testing supply chain. Currently, the federal government is not meeting its responsibility to coordinate testing capacity among states and Indian Tribes and is failing to release crucial information to the public. We urge you to provide public transparency and leadership without delay.

Over three weeks after President Trump declared the COVID-19 outbreak a national emergency, we continue to hear from our states and Tribal Nations about the lack of supplies and testing kits to diagnose our constituents for the coronavirus. State departments of health, Indian Tribes, hospitals, health care providers, and first responders lack the tests and equipment—including personal protective equipment (PPE), testing swabs, and reagents—needed to conduct adequate public health surveillance to contain and stop the spread of coronavirus.

Widespread diagnostic testing is crucial to controlling the COVID-19 outbreak. In the short term, quickly obtaining test results for hospitalized patients allows hospitals to preserve supplies of PPE and prevents unnecessary quarantines of front-line health care workers and first responders. In the long run, experts have argued that widespread testing will be needed to track and contain COVID-19 cases, allowing communities to slowly lift general social distancing restrictions without putting the public at risk. 

The lack of tests is reportedly forcing the administration, in concert with private actors, to funnel available supplies to certain areas.  For example, Abbott Labs, which recently developed a rapid 5-minute COVID-19 diagnostic test, said it is, “working with the administration to deploy the tests to areas where they can have the greatest impact,” like COVID-19 hot spots. This may explain why, even though the Food and Drug Administration (FDA) has now issued emergency use authorizations (EUAs) for 32 COVID-19 diagnostic tests, many of our states and Tribal Nations have not seen the benefit of this rapid private-sector innovation. While it is important to provide tests for COVID-19 hot spots, tests cannot be limited to those areas. Without prompt and sufficient access to coronavirus tests, we risk exacerbating outbreaks and becoming a nation of hot spots.

Furthermore, the decentralized system of tracking tests and the corresponding lack of transparency into when and where these tests are being sent makes it challenging for our nation as a whole to systemically plan its public health response to the COVID-19 outbreak. Currently, hospitals are finding that some labs are working through significant backlogs, leaving samples untested for days or weeks, while others are able to turn results around quickly, within 24 to 48 hours. Without detailed information about the capacity and turnaround time for each lab, it is impossible to efficiently distribute testing capacity on the nationwide scale that is required by this crisis. Given the Administration’s track record of over-promising and under-delivering on testing for COVID-19, the public deserves full transparency about our national capacity for COVID-19 testing, including where tests are available, how many have been conducted, which patients have access to testing, and what the results of these tests revealed. 

These persistent gaps in the availability of COVID-19 diagnostic tests and the lack of public transparency about where tests are available raise the need for a national inventory of COVID-19 diagnostic tests. The recently passed Coronavirus Aid, Relief, and Economic Security (CARES) Act granted HHS the authority to collect test results from any laboratory. Additionally, you recently wrote to hospitals asking them to report their internal test results to the Federal Emergency Management Agency (FEMA) on a daily basis, although this requirement does not apply to tests conducted by commercial and academic labs. We urge you to extend data collection efforts to commercial and academic labs, coordinate data collection between each agency, the Indian Tribes, and the states, and make the resulting information available to the public as rapidly as possible.

Specifically, this public-facing inventory should provide real-time data that answer the following questions:

  1. How many COVID-19 diagnostic tests are available on a daily basis, and to which states and Tribes are manufacturers sending these tests? How many of these tests screen for coronavirus antibodies?
  2. To which public health, academic, and commercial laboratories are COVID-19 diagnostic test manufacturers sending tests, and how many tests are being sent to these labs?
  3. Which laboratories—public health, academic, and commercial—can run COVID-19 diagnostic tests, and what is their daily capacity to run these tests? Please provide a breakdown of this information by lab type, test type, and state if possible.
  4. What is the wait time for laboratories to process and receive results for COVID-19 tests?  Do providers have to wait minutes, hours, or days to receive their patients’ results?
  5. What supplies do America’s public health, academic, and commercial laboratories need on hand to run at full capacity to process COVID-19 tests? Which of these supplies are in shortage, and what steps is the Administration taking to expand the capacity of these supplies? 

Additionally, we request answers to the following questions:

  1. In a March 10 interview, Secretary Azar referenced an “IT reporting system… to keep track of how many we’re testing.” What is the status of this system? What information is tracked in this system?
  2. Will the Task Force commit to making all collected information about testing capacity and volume publicly available with daily updates, and to release relevant information on testing results?
  3. Which federal agency is managing the supply chain and distribution of tests and testing supplies to states, territories, and Indian Tribes?  Which official is leading the testing supply and distribution effort within that agency? 

We urge you to promptly develop a national, real-time, public-facing inventory of COVID-19 diagnostic tests and results.  This resource will provide the transparency that our states and Tribal Nations need to anticipate the national testing supply chain and the information that the federal government needs to anticipate and proactively address any testing shortages.

Sincerely,

###

 

WASHINGTON – Today, U.S. Sen. Mark R. Warner (D-VA), a member of the Senate Finance Committee, joined his Senate Democratic colleagues in pressing the U.S. Department of Labor (DOL) to ensure workers Congress intended to be covered by the Pandemic Unemployment Assistance Program receive the benefits they deserve. The program, which was established in the CARES Act, is intended to make sure that individuals who would normally not qualify for unemployment benefits under state law, but are currently unemployed, unable, or unavailable to work as a direct result of the COVID-19 health crisis, are eligible to receive unemployment compensation.

“[P]arts of the guidance appear narrow or ambiguous, which could make states think they need to exclude workers who Congress clearly intended to receive unemployment compensation through the Pandemic Unemployment Assistance (PUA) program,” wrote the Senators in their letter to Secretary of Labor Eugene Scalia.

In the letter, the Senators are requesting the Department of Labor clarify its guidance pertaining to workers who have been diagnosed with COVID-19 without receiving a test, workers with COVID-19 who take time off of work, workers without child care options in summer months, workers unable to get to work due to stay-at-home orders, workers with underlying health conditions like asthma, and self-employed workers like gig workers who are unable to work due to plummeting demand for their services.

Earlier this month, Sen. Warner sent a letter to Secretary Scalia calling on the federal agency to streamline the Pandemic Unemployment Assistance (PUA) process by issuing additional, more comprehensive guidance to states so they can quickly implement the unemployment provisions in the CARES Act and ensure that gig workers are able to access unemployment benefits in the midst of the growing economic emergency. Among other recommendations, the letter called on the Department of Labor to take the lead with innovative technological solutions for administration of the PUA that states could use in order to facilitate the process and limit the need to stand up new state-level solutions.

In addition to Sen. Warner, today’s letter was led by Sen. Ron Wyden (D-OR), Minority Leader Chuck Schumer (D-NY) and co-signed by Sens. Patrick Leahy (D-VT), Sherrod Brown (D-OH), Patty Murray (D-WA), Chris Van Hollen (D-MD), Michael Bennet (D-CO), Ed Markey (D-MA), Doug Jones (D-AL), Sheldon Whitehouse (D-RI), Angus King (D-VT), Bob Menendez (D-NJ), Cory Booker (D-NJ), Ben Cardin (D-MD), Kirsten Gillibrand (D-NY), Mazie Hirono (D-HI), Amy Klobuchar (D-MN), Tom Carper (D-DE), Richard Blumenthal (D-CT), Debbie Stabenow (D-MI), Tina Smith (D-MN), Tammy Duckworth (D-IL), Bob Casey (D-PA), Elizabeth Warren (D-MA), Bernie Sanders (I-VT), Dianne Feinstein (D-CA), Dick Durbin (D-IL), Jeff Merkley (D-OR), Jack Reed (D-RI), Catherine Cortez Masto (D-NV), Jacky Rosen (D-NV), Maria Cantwell (D-WA), and Tom Udall (D-NM). 

A copy of the letter can be found here and below. A list of Sen. Warner’s work to protect Americans amid the COVID-19 outbreak is available here.

 

The Honorable Eugene Scalia

Secretary of Labor

U.S. Department of Labor

200 Constitution Ave. NW

Washington, DC 20210

Dear Secretary Scalia: 

Thank you for entering into agreements with states and territories and issuing some of the key guidance needed to implement new federal unemployment compensation programs on April 4 and April 5, 2020 (Unemployment Insurance Program Letter [UIPL] Numbers 15-20 and 16-20). This guidance is essential to start getting more unemployment benefits to workers across the country, including self-employed and other workers who are not covered by the traditional Unemployment Insurance (UI) program. 

We understand that the examples of covered workers provided in the guidance are not intended to be exhaustive. However, parts of the guidance appear narrow or ambiguous, which could make states think they need to exclude workers who Congress clearly intended to receive unemployment compensation through the Pandemic Unemployment Assistance (PUA) program.

We request that the Department of Labor (the Department) issue additional guidance on the issues described below no later than Friday, April 17. Understanding that you are still working diligently to release guidance for several CARES Act programs, if you are unable to issue clarifying guidance by Friday, April 17, we request a written response to this letter providing a timeline for issuing clarifying guidance and detailing how you intend to address these issues.

  1. The Department’s guidance for sections 2102(a)(3)(A)(ii)(I)(aa), (bb), and (ff) reference circumstances under which an individual testing positive for COVID-19 is a possible qualification for a person receiving PUA. In the CARES Act, Congress deliberately used language referring to a “diagnosis” rather than “tested positive”, knowing testing shortages, delays in test results, and guidance instructing people to stay home rather than travel to medical facilities could make testing-based criteria difficult to meet. Furthermore, if someone suspects they have COVID-19 but can care for themselves at home, the Centers for Disease Control and Prevention (CDC) recommends they recover at home to avoid infecting others.  

We are pleased that the language in the Department’s guidance says that someone may qualify for PUA if they have tested positive or received a diagnosis, but we request that the Department make crystal clear that while a positive test would be sufficient to qualify for PUA under these provisions, a qualifying diagnosis never requires a positive test. Any diagnosis from a health care provider, including one made via phone or telehealth, is also sufficient for a person to qualify for PUA.  

  1. The two examples provided in UIPL 16-20 Attachment I (C)(1)(a) of the guidance for an individual who might qualify for unemployment benefits under section 2102(a)(3)(A)(ii)(I)(aa) of the CARES Act based on their own illness both involve an individual who must quit a job. This provision of the CARES Act also covers any individual who is forced to take unpaid time off work for the reasons described, regardless of whether their employment relationship is formally severed. The guidance should be clarified to ensure that such individuals are covered. 
  1. Section 2102(a)(3)(A)(ii)(I)(dd) of the CARES Act says an individual may qualify for PUA if “a child or other person in the household for which the individual has primary caregiving responsibility is unable to attend school or another facility that is closed as a direct result of the COVID–19 public health emergency and such school or facility care is required for the individual to work.” The guidance in UIPL 16-20 Attachment I (C)(1)(d) provides accurate examples of situations in which a caregiver could qualify for PUA under this provision.

However, the guidance later states that “a school is not closed as a direct result of the COVID-19 public health emergency, for purposes of section 2102(a)(3)(A)(ii)(I)(dd), after the date the school year was originally scheduled to end.” Many families rely on child care, summer camp, or other facilities (including school facilities) to care for their children in the summer and those facilities may remain closed as a result of COVID-19. The guidance should be clarified to confirm that individuals may qualify under section 2102(a)(3)(A)(ii)(I)(dd) during the summer months, for families that rely on any of those facilities.

  1. Section 2102(a)(3)(A)(ii)(I)(ee) of the CARES Act says that an individual who is “unable to reach the place of employment because of a quarantine imposed as a direct result of the COVID–19 public health emergency” may qualify for PUA. The example of a quarantine provided in UIPL 16-20 Attachment I (C)(1)(e) of the Department’s guidance describes “a state or municipal order restricting travel” preventing an individual from getting to work. We are concerned that using the language of “restricting travel” may be too narrow to capture all of types of quarantine orders that are covered under this provision of the CARES Act. The guidance should clarify that such an order includes any stay-at-home, shelter-in-place, social distancing, or other order that requires individuals to stay home in quarantine to reduce the spread of COVID-19.

Similarly, UIPL 16-20 Attachment I (C)(1)(g) references a “state or municipal order restricting travel” with respect to section 2102(a)(3)(A)(ii)(I)(gg) of the CARES Act. This should also be clarified as described above.

  1. Section 2102(a)(3)(A)(ii)(I)(ff) of the CARES Act says that an individual who is “unable to reach the place of employment because the individual has been advised by a health care provider to self-quarantine due to concerns related to COVID–19” may qualify for PUA. The examples specified in the Department’s guidance describe a person who suspects they are infected with COVID-19 and a person who is immune-compromised because of a serious health condition.  

The reference to a person “whose immune system is compromised by virtue of a serious health condition” in the guidance does not cover the wide range of reasons a health care provider may advise self-quarantine. For example, while the CDC considers older Americans more at risk of serious complications from COVID-19, states may not think they are covered under Department’s guidance. Furthermore, workers with certain health conditions (such as a respiratory condition) may not technically have a compromised immune system but would be at increased risk from COVID-19 and may need to self-quarantine. As we learn more about COVID-19, we may discover that there are other populations at risk too.

The Department needs to clarify that anyone advised by a health care provider to self-quarantine due to increased risk of COVID-19 should be covered by PUA, regardless of the underlying reason for their increased risk.

  1. We are pleased that the Secretary established additional criteria under section 2102(a)(3)(A)(ii)(I)(kk) of the CARES Act to clarify that self-employed individuals such as independent contractors who may not have one specific place of employment are covered by PUA, in keeping with the intent of the legislation. While we believe that such workers are covered by the text of the law, we appreciate the Department’s action to eliminate ambiguity and ensure these workers receive benefits.

However, to avoid any confusion about who should qualify under UIPL 16-20 Attachment I (C)(1)(k), the Department must clarify that an independent contractor who is unable to work and forced to suspend work activities because there is reduced demand for their services also qualifies for PUA benefits. Many independent contractors have seen demand for their services dry up as a direct result of COVID-19. In the example of a ride share driver, a driver should be able to claim PUA when they are forced to suspend their work because there are too few customers seeking rides. For an independent contractor, losing many or all of their customers overnight is analogous to an employee being laid off by an employer, or, as the Department’s guidance notes, their “place of employment” being closed. Congress created the PUA program with the intent to cover workers like independent contractors and gig workers who may not have traditional employment relationships, but who have suddenly lost their livelihoods during this time of crisis. We believe that that the CARES Act definitively covers such workers, and the Department should clarify its guidance to reflect this.

  1. The Department’s guidance says that “States should bear in mind that many of the qualifying circumstances described in section 2102(a)(3)(A)(ii)(I) are likely to be of short term duration.” Although we agree that some individuals may qualify for PUA for only a short period, many applicants will rely on PUA for longer periods, especially if this public health crisis persists. Furthermore, the way an individual qualifies for PUA may vary from week to week. For example, someone could first qualify if they get sick with COVID-19, then their child’s school may close as they recover, and they would qualify based on the new circumstance.

The Department’s guidance should encourage states to consider this as they create PUA application systems. It would be inefficient for both the claimant and the state workforce agency if individuals have to file a new initial application each time their qualifying circumstance changes. Individuals continue to qualify for benefits as long as they continue to meet at least one of the qualifying circumstances described in section 2102(a)(3)(A)(ii)(I), even if the precise provision under which they qualify changes.

  1. We have heard conflicting reports of whether the Department’s guidance allows for the addition of the $600 federal supplement to PUA benefits in U.S. territories that do not have UI programs. The guidance the Department has issued for Federal Pandemic Unemployment Compensation and PUA is ambiguous on this matter.

Section 2102(d) of the CARES Act says that for an individual who lives in these territories, “the assistance authorized under subsection (b) for a week of unemployment shall be calculated in accordance with section 625.6 of title 20, Code of Federal Regulations, or any successor thereto, and shall be increased by the amount of Federal Pandemic Unemployment Compensation under section 2104.” This language makes clear that the “amount of Federal Pandemic Unemployment Compensation” ($600) should be included in the PUA benefit amount for anyone qualifying for PUA in any of the territories. We would appreciate if the Department would clarify this matter to facilitate the administration and payment of benefits in these territories.

In addition to the concerns we have raised above, we know that states will have additional questions as they continue to implement PUA and other CARES Act programs. We urge the Department to respond to questions from states as quickly as possible to avoid causing any delay in the processing of benefits.

Thank you for your attention to this important matter.

Sincerely,

###

WASHINGTON – U.S. Sens. Mark R. Warner (D-VA) and Richard Blumenthal (D-CT) along with U.S. Rep. Anna Eshoo (D-CA) today sent a letter to White House Senior Advisor Jared Kushner, raising questions about reports that the White House has assembled technology and health care firms to establish a far-reaching national coronavirus surveillance system. In the letter, the members of Congress expressed concerns that the White House has not been fully transparent about the effort, particularly in light of the significant data privacy issues associated with sharing Americans’ personal health information with corporations that have a checkered history when it comes to protecting patient and user privacy.

“While we support greater efforts to track and combat the spread of COVID-19 – and have been alarmed by the notably delayed response to the crisis by this Administration – we have serious concerns with the secrecy of these efforts and their impact on the health privacy of all Americans. Your office’s denial of the existence of this effort, despite ample corroborating reporting, only compounds concerns we have with lack of transparency,” the members of Congress wrote to Mr. Kushner. 

In the letter, the members noted that Health Insurance Portability and Accountability Act (HIPPA), which Congress passed in 1996, failed to foresee the recent boom in health technologies allowing medical data to be shared without patient or doctor consent, enabling companies that have previously been accused of privacy abuses to handle sensitive patient data without strong privacy protections. The reported establishment of far-reaching public health surveillance infrastructure in collaboration with large technology firms, against the backdrop of these failures of HIPAA, raises important privacy concerns. 

“This growing health pandemic further exacerbates increasing concerns about the role large tech firms are starting to play in our health care sector. Health care entities are increasingly entering into secret data sharing partnerships with dominant technology platforms. These partnerships have bolstered the platforms’ ability to exploit consumer data and leverage their hold on data into nascent markets such as health analytics. Contrary to the fundamental, animating principle of HIPAA, this encroachment is occurring without the knowledge or consent of doctors or patients through opaque business agreements and exceptions. We fear that further empowering technology firms and providing unfettered access to sensitive health information during the COVID-19 pandemic could fatally undermine health privacy in the United States,” wrote the members of Congress.

Added Sen. Warner, Sen. Blumenthal and Rep. Eshoo, “Similarly, we have tragically seen that COVID-19 is following and exacerbating existing health disparities and inequalities among racial, ethnic, and socioeconomic groups. A public health surveillance system should be able capture these parameters in order to ensure our response addresses the heightened risk to these communities. Yet we must be cautious about the impact and further use of this sensitive information, which also poses fraught risk for bias and civil rights violations, as we have seen when algorithmic systems used in calculating health premiums, employment determinations, and credit evaluations have led to discriminatory outcomes.”

The members requested responses to the following questions:

  1. Which technology companies, data providers, and other companies have you approached to participate in the public health surveillance initiative and on what basis were they chosen?
  2. What measures will the Administration put into place to ensure that federal agencies and private sector partners do not misuse or reuse health data for non-pandemic-related purposes, including for training commercial algorithmic decision-making systems, and to require the disposal of data after the sunset of the national emergency? What additional steps have you taken to protect health data from their potential misuse or mishandling?
  3. What is the program described in the press meant to accomplish? Will it be used for the allocation of resources, symptom tracking, or contact tracing? What agency will be operating the program and which agencies will have access to the data? 
  4. When will the federal government stop collecting and sharing health data with the private sector for the public health surveillance initiative? Will the Administration commit to a sunset period after the lifting of the national emergency?
  5. What measures will the Administration put into place to ensure that the public health surveillance initiative protects against misuse of sensitive information and mitigates discriminatory outcomes, such as on the basis of racial identity, sexual orientation, disability status, and income?
  6. Will the Administration commit to conducting an audit of data use, sharing, and security by federal agencies and private sector partners under any waivers or surveillance initiative within a short period after the end of the health emergency?
  7. What steps has the Administration taken under the Privacy Act, which limits the federal government's authority to collect personal data from third parties and imposes numerous other privacy safeguards?
  8. Will you commit to working with us to pass strong legal safeguards that ensure public health surveillance data can be effectively collected and used without compromising privacy?

Sen. Warner has previously raised concerns that enforcement of existing patient privacy law has not kept up with technological advancement when it comes to the use and sharing of confidential medical data and called for updating laws, including new protections to govern collection, processing, and retention of public health surveillance data.

A copy of the letter is available here, and the full text appears below. A list of Sen. Warner’s work to protect Americans amid the COVID-19 outbreak is available here.

 

April 10, 2020

Jared Kushner

Senior Advisor to the President

The White House

1600 Pennsylvania Ave NW

Washington, DC  20500

Dear Mr. Kushner: 

We write you in the wake of reports that you have assembled a range of technology firms and health care providers to establish a far-reaching public health surveillance system in response to the COVID-19 pandemic. While we support greater efforts to track and combat the spread of COVID-19 – and have been alarmed by the notably delayed response to the crisis by this Administration – we have serious concerns with the secrecy of these efforts and their impact on the health privacy of all Americans. Your office’s denial of the existence of this effort, despite ample corroborating reporting, only compounds concerns we have with lack of transparency.

In response to the spread of COVID-19, the Department of Health and Human Services (HHS) has promulgated a number of guidance documents that attenuate or waive privacy protections normally attached to protected health information. Many of these measures, such as disclosure of a patient’s COVID-19 diagnosis to protect first responders, are warranted during this health emergency. However, we fear that – absent a clear commitment and improvements to our health privacy laws – these extraordinary measures could undermine the confidentiality and security of our health information and become the new status quo. 

It is increasingly apparent that Health Insurance Portability and Accountability Act’s (HIPPA) Privacy and Security rules have not aged well. We have seen numerous examples of the limits of HIPAA undermining the strong protections we have come to expect of our sensitive health information. For example, there are rumors in the press that Administration is promoting a COVID-19 screening registration tool offered by Verily, which is owned by Google’s parent company Alphabet. That site is inexplicably not covered under HIPAA.  

This growing health pandemic further exacerbates increasing concerns about the role large tech firms are starting to play in our health care sector. Health care entities are increasingly entering into secret data sharing partnerships with dominant technology platforms. These partnerships have bolstered the platforms’ ability to exploit consumer data and leverage their hold on data into nascent markets such as health analytics. Contrary to the fundamental, animating principle of HIPAA, this encroachment is occurring without the knowledge or consent of doctors or patients through opaque business agreements and exceptions. We fear that further empowering technology firms and providing unfettered access to sensitive health information during the COVID-19 pandemic could fatally undermine health privacy in the United States.

Given reports indicating that the Administration has solicited help from companies with checkered histories in protecting user privacy, we have serious concerns that these public health surveillance systems may serve as beachheads for far-reaching health data collection efforts that go beyond responding to the current crisis. Public health surveillance efforts must be accompanied by governance measures that provide durable privacy protections and account for any impacts on our rights. For instance, secondary uses of public health surveillance data beyond coordinating our public health response should be strictly restricted. Any secondary usage for commercial purposes should be explicitly prohibited unless authorized on a limited basis with appropriate administrative process and public input. 

Similarly, we have tragically seen that COVID-19 is following and exacerbating existing health disparities and inequalities among racial, ethnic, and socioeconomic groups. A public health surveillance system should be able capture these parameters in order to ensure our response addresses the heightened risk to these communities. Yet we must be cautious about the impact and further use of this sensitive information, which also poses fraught risk for bias and civil rights violations, as we have seen when algorithmic systems used in calculating health premiums, employment determinations, and credit evaluations have led to discriminatory outcomes.

Our urgent and forceful response to COVID-19 can coexist with protecting and even bolstering our health privacy. If not appropriately addressed, these issues could lead to a breakdown in public trust that could ultimately thwart successful public health surveillance initiatives. We encourage you to think seriously about these issues. To that end, we request that you respond to the following questions we have on your current effort:

  1. Which technology companies, data providers, and other companies have you approached to participate in the public health surveillance initiative and on what basis were they chosen?
  2. What measures will the Administration put into place to ensure that federal agencies and private sector partners do not misuse or reuse health data for non-pandemic-related purposes, including for training commercial algorithmic decision-making systems, and to require the disposal of data after the sunset of the national emergency? What additional steps have you taken to protect health data from their potential misuse or mishandling?
  3. What is the program described in the press meant to accomplish? Will it be used for the allocation of resources, symptom tracking, or contact tracing? What agency will be operating the program and which agencies will have access to the data? 
  4. When will the federal government stop collecting and sharing health data with the private sector for the public health surveillance initiative? Will the Administration commit to a sunset period after the lifting of the national emergency?
  5. What measures will the Administration put into place to ensure that the public health surveillance initiative protects against misuse of sensitive information and mitigates discriminatory outcomes, such as on the basis of racial identity, sexual orientation, disability status, and income?
  6. Will the Administration commit to conducting an audit of data use, sharing, and security by federal agencies and private sector partners under any waivers or surveillance initiative within a short period after the end of the health emergency?
  7. What steps has the Administration taken under the Privacy Act, which limits the federal government's authority to collect personal data from third parties and imposes numerous other privacy safeguards?
  8. Will you commit to working with us to pass strong legal safeguards that ensure public health surveillance data can be effectively collected and used without compromising privacy?  

Thank you for your prompt attention and responses to these important questions.

Sincerely, 

###